JPH05201968A - Synthetic intermediate for 1beta-substituted carbapenem - Google Patents

Synthetic intermediate for 1beta-substituted carbapenem

Info

Publication number
JPH05201968A
JPH05201968A JP4174099A JP17409992A JPH05201968A JP H05201968 A JPH05201968 A JP H05201968A JP 4174099 A JP4174099 A JP 4174099A JP 17409992 A JP17409992 A JP 17409992A JP H05201968 A JPH05201968 A JP H05201968A
Authority
JP
Japan
Prior art keywords
group
formula
compound
carbon atoms
isomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP4174099A
Other languages
Japanese (ja)
Other versions
JP3175857B2 (en
Inventor
Akira Yoshida
明 吉田
Kozo Oda
晃造 小田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Priority to JP17409992A priority Critical patent/JP3175857B2/en
Publication of JPH05201968A publication Critical patent/JPH05201968A/en
Application granted granted Critical
Publication of JP3175857B2 publication Critical patent/JP3175857B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PURPOSE:To provide a compound useful as a synthetic intermediate for 1- substituted carbapenem derivative which is known as an excellent antibacterial agent. CONSTITUTION:The compound of formula I [R<1> is H or OH-protecting group; R<2> is 1-6C alkyl, 1-6C alkoxy, halogen, etc.; R<3> is CYNR<5>R<6> (Y is O or S; R<5> and R<6> are 1-6C alkyl, aryl, aralkyl, etc.); R<4> is H or amino-protecting group)], e.g. (2R)-2-[(3S,4S)--3-[(R)-1-(t-butyldimethylsilyloxy)ethyl]-2-oxo-4- azetidinyl]thiopropionic acid S-(2-diethylaminocarbonylphenyl) ester. The compound of formula I can be produced by reacting a silyl enol ether of formula II (R<8> to R<10> are 1-4C alkyl or phenyl; Z is 0 or S) with an azetidinone derivative of formula III (R<11> is acyloxy, alkylsulfonyl, etc.) in the presence of a Lewis acid (e.g. zinc oxide) in a solvent (e.g. methylene chloride) at -10 to +70 deg.C.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明の化合物(I)は、すぐれ
た抗菌剤である1−置換カルバペネム誘導体の合成の有
用な中間体である。
The compound (I) of the present invention is a useful intermediate in the synthesis of 1-substituted carbapenem derivatives which are excellent antibacterial agents.

【0002】[0002]

【従来の技術】強力な抗菌活性を有するカルバペネム抗
生物質の1β位に置換基を導入すると化学的に安定にな
るのみならず、生体内に存在するジヒドロペプチダーゼ
I(DHP-I) に対しても安定になることが見出された。1
β位に置換基をもつカルバペネム抗生物質は天然に得ら
れていないので合成によってそれらをつくる必要があ
り、その合成法が大変注目され、種々の合成法が検討さ
れている。その合成法のひとつとしてチオプロピオン酸
S−フェニルエステルから得られたシリルエノールエー
テルと(3R,4R)−3−[(1R)−1−t−ブチ
ルジメチルシリルオキシ)エチル]−4−アセトキシ−
2−アゼチジノンまたはその1−トリメチルシリル誘導
体との反応によって1β−メチルカルバペネム抗生物質
の鍵中間体である2R−異性体(a)が合成されてい
る。[T.Shibata et al,Tetrahedron Letters,26 ,4793
(1985);C.U.Kim et al,Tetrahedron Letters,28,507(19
87);A.Martel et al,Can.J.Chem.,66,1537(1988)]。し
かしながらこれらの方法では望ましい2R−チオプロピ
オン酸誘導体とその2S−異性体の比がそれぞれ、1.
6/1,1/19,1/9であり望ましい2R−異性体
を合成する方法として満足のいくものでなかった。
2. Description of the Related Art Introducing a substituent at the 1β-position of a carbapenem antibiotic having strong antibacterial activity not only makes it chemically stable but also protects against dihydropeptidase I (DHP-I) existing in the body. It was found to be stable. 1
Carbapenem antibiotics having a substituent at the β-position have not been obtained naturally, so it is necessary to make them synthetically, and the synthetic method has received a great deal of attention, and various synthetic methods have been studied. As one of the synthetic methods, silyl enol ether obtained from thiopropionic acid S-phenyl ester and (3R, 4R) -3-[(1R) -1-t-butyldimethylsilyloxy) ethyl] -4-acetoxy-
The 2R-isomer (a), which is a key intermediate of 1β-methylcarbapenem antibiotics, has been synthesized by reaction with 2-azetidinone or its 1-trimethylsilyl derivative. [T.Shibata et al, Tetrahedron Letters, 26 , 4793
(1985); CUKim et al, Tetrahedron Letters, 28 , 507 (19
87); A. Martel et al, Can. J. Chem., 66 , 1537 (1988)]. However, in these methods, the ratio of desirable 2R-thiopropionic acid derivative and its 2S-isomer is 1.
6/1, 1/19, 1/9, which was not a satisfactory method for synthesizing the desired 2R-isomer.

【0003】[0003]

【化2】 [Chemical 2]

【0004】[0004]

【発明の解決しようとしている課題】発明者らは、フェ
ニル基が置換基としてアミド基をもつチオプロピオン酸
S−フェニルエステルから導かれたシリルエノールエー
テルが望ましい2R−チオプロピオン酸誘導体をより選
択的に与えることを見出し本発明を完成した。
DISCLOSURE OF THE INVENTION The present inventors have more selective a 2R-thiopropionic acid derivative in which a silyl enol ether derived from thiopropionic acid S-phenyl ester in which a phenyl group has an amide group as a substituent is desirable. The present invention has been completed.

【0005】[0005]

【課題を解決するための手段】本発明は、一般式The present invention has the general formula

【0006】[0006]

【化3】 [Chemical 3]

【0007】を有する化合物である。Is a compound having

【0008】上記式中、R1 は水素原子または水酸基の
保護基を示し、R2 は炭素数1乃至6個の直鎖若しくは
分枝鎖のアルキル基、炭素数1乃至6個の直鎖若しくは
分枝鎖のアルコキシ基、ハロゲン原子、無置換若しくは
下記α群から選択された置換分を有するフェニル基又は
無置換若しくは下記α群から選択された置換分を有する
フェノキシ基を示し、R3 はCYNR56 基(式中、
Yは酸素又は硫黄原子を示し、R5 及びR6はそれぞれ
独立に炭素数1乃至6個の直鎖若しくは分枝鎖のアルキ
ル基、無置換若しくは下記α群から選択された置換分を
有するアリ−ル基又は無置換若しくは下記α群から選択
された置換分を有するアラルキル基を示すか、R5 とR
6 が一緒になって式−(CH2)m(X)L(CH2)n−基(式中、m
及びnは同一又は異って0乃至5(但し、m+nは2以
上である。)を示し、Lは0または1、Xは酸素、硫黄
原子またはNR7 基(R7 は炭素数1乃至6個の直鎖若
しくは分枝鎖のアルキル基、炭素数1乃至6個の直鎖若
しくは分枝鎖の脂肪族アシル基、無置換若しくは下記α
群から選択された置換分を有する芳香族アシル基を示
す。)を示す。)を示す。)を置換基として有してお
り、かつ、下記α群から選択された置換分を有してもよ
いフェニル基を示し、R4 は水素原子又はアミノ基の保
護基を示し、Zは酸素又は硫黄原子を示す。前記一般式
において、R2 及びα群のハロゲン原子は、フッ素、塩
素及び臭素であり、好適にはフッ素及び塩素である。
In the above formula, R 1 represents a hydrogen atom or a hydroxyl-protecting group, R 2 represents a linear or branched alkyl group having 1 to 6 carbon atoms, a straight chain having 1 to 6 carbon atoms or A branched-chain alkoxy group, a halogen atom, a phenyl group having an unsubstituted or a substituent selected from the following α group or a phenoxy group having an unsubstituted or a substituent selected from the following α group, R 3 is CYNR 5 R 6 groups (in the formula,
Y represents an oxygen atom or a sulfur atom, R 5 and R 6 are each independently a straight-chain or branched-chain alkyl group having 1 to 6 carbon atoms, an unsubstituted or substituted substituent selected from the α group below. Or an aralkyl group which is unsubstituted or has a substituent selected from the following α group, or R 5 and R
6 together formula - (CH 2) m (X ) L (CH 2) n - group (wherein, m
And n are the same or different and represent 0 to 5 (provided that m + n is 2 or more), L is 0 or 1, X is oxygen, a sulfur atom or an NR 7 group (R 7 is a carbon number of 1 to 6). Straight-chain or branched-chain alkyl groups, straight-chain or branched-chain aliphatic acyl groups having 1 to 6 carbon atoms, unsubstituted or the following α
An aromatic acyl group having a substituent selected from the group is shown. ) Is shown. ) Is shown. ) As a substituent and which may have a substituent selected from the following α group, R 4 represents a hydrogen atom or an amino-group protecting group, Z represents oxygen or Indicates a sulfur atom. In the above general formula, the halogen atom of R 2 and α group is fluorine, chlorine and bromine, and preferably fluorine and chlorine.

【0009】R1 の水酸基の保護基は、カルバペネム誘
導体合成に常用される水酸基の保護基であり、好適には
t−ブチルジメチルシリル、t−ブチルジフェニルシリ
ル、トリメチルシリル、トリエチルシリル基のようなト
リ置換シリル基、ベンジルオキシカルボニル、p−ニト
ロベンジルオキシカルボニル基のようなアラルキルオキ
シカルボニル基、アセチル、クロロアセチル、メトキシ
アセチルのような置換していてもよいアセチル基であ
る。
The hydroxyl group-protecting group for R 1 is a hydroxyl group-protecting group commonly used in the synthesis of carbapenem derivatives, and is preferably a tri-group such as t-butyldimethylsilyl, t-butyldiphenylsilyl, trimethylsilyl and triethylsilyl groups. It is a substituted silyl group, an aralkyloxycarbonyl group such as benzyloxycarbonyl or p-nitrobenzyloxycarbonyl group, or an optionally substituted acetyl group such as acetyl, chloroacetyl or methoxyacetyl.

【0010】R4 のアミノ基の保護基としては、カルバ
ペネム誘導体合成に常用されるアミノ基の保護基であ
り、好適には、t−ブチルジメチルシリル、t−ブチル
ジフェニルシリル、トリメチルシリル、トリエチルシリ
ル基のようなトリ置換シリル基である。
The amino-protecting group for R 4 is an amino-protecting group commonly used in the synthesis of carbapenem derivatives, and is preferably t-butyldimethylsilyl, t-butyldiphenylsilyl, trimethylsilyl or triethylsilyl group. Is a tri-substituted silyl group.

【0011】R2 、R5 、R6 及びR7 の炭素数1乃至
6個の直鎖若しくは分枝鎖のアルキル基としては、メチ
ル、エチル、プロピル、i−ブチル、ペンチル、ヘキシ
ル基等があげられ、好適には、メチル、エチル基であ
る。
Examples of the linear or branched alkyl group having 1 to 6 carbon atoms of R 2 , R 5 , R 6 and R 7 include methyl, ethyl, propyl, i-butyl, pentyl and hexyl groups. And preferably a methyl group or an ethyl group.

【0012】R2 の炭素数1乃至6個の直鎖若しくは分
枝鎖のアルコキシ基のアルキル部分としては、前記アル
キル基と同様のものがあげられ、好適には、メトキシ、
エトキシ基である。
Examples of the alkyl moiety of the straight-chain or branched-chain alkoxy group having 1 to 6 carbon atoms for R 2 include those similar to the above-mentioned alkyl groups, and preferably methoxy,
It is an ethoxy group.

【0013】R7 の炭素数1乃至6個の直鎖若しくは分
枝鎖の脂肪族アシル基のアルキル部分としては、メチ
ル、エチル、プロピル、i−ブチル、ペンチル基等があ
げられ、好適には、メチル、エチル基である。
Examples of the alkyl moiety of the linear or branched aliphatic acyl group having 1 to 6 carbon atoms for R 7 include methyl, ethyl, propyl, i-butyl, pentyl group, and the like. , Methyl and ethyl groups.

【0014】α群の炭素数1乃至4個のアルキルアミノ
基及び炭素数1乃至4個のアルキル基を2個有するジア
ルキルアミノ基のアルキル部分としては、前記アルキル
基と同様のものがあげられ、好適には、プロピル、i−
ブチル基である。
Examples of the alkyl moiety of the α-group alkylamino group having 1 to 4 carbon atoms and the dialkylamino group having 2 alkyl groups having 1 to 4 carbon atoms include those similar to the above alkyl groups. Suitably, propyl and i-
It is a butyl group.

【0015】R3 のCYNR56 基のR5 及びR6
無置換若しくは下記α群から選択された置換分を有する
アリ−ル基及び無置換若しくは下記α群から選択された
置換分を有するアラルキル基並びR7 の無置換若しくは
下記α群から選択された置換分を有する芳香族アシル基
のアリール部分としては、好適にはフェニル基である。
The substituents selected from Le group and an unsubstituted or below α group - [0015] ants having substituents selected from unsubstituted or below α group of R 5 and R 6 CYNR of 5 R 6 groups R 3 The aryl portion of the aromatic aralkyl group which has an unsubstituted aralkyl group or a substituent selected from the following α group of the aralkyl group having R 7 is preferably a phenyl group.

【0016】α群の炭素数1乃至3個のアルキレンジオ
キシ基としては、好適には、メチレンジオキシ基であ
る。
The alkylenedioxy group having 1 to 3 carbon atoms in the α group is preferably a methylenedioxy group.

【0017】本発明の一般式(I)を有する化合物の具
体例としては、例えば表1乃至8に記載する化合物をあ
げることができるが、本発明はこれら化合物に限定され
るものではない。
Specific examples of the compound having the general formula (I) of the present invention include the compounds shown in Tables 1 to 8, but the present invention is not limited to these compounds.

【0018】なお、表1乃至4については式(I−
1)、表5乃至8については式(I−2)を用いる。
In Tables 1 to 4, the formula (I-
1) and Tables 5 to 8 use the formula (I-2).

【0019】[0019]

【化4】 [Chemical 4]

【0020】[0020]

【表1】 [Table 1]

【0021】[0021]

【表2】 [Table 2]

【0022】[0022]

【表3】 [Table 3]

【0023】[0023]

【表4】 [Table 4]

【0024】[0024]

【表5】 [Table 5]

【0025】[0025]

【表6】 [Table 6]

【0026】[0026]

【表7】 [Table 7]

【0027】[0027]

【表8】 [Table 8]

【0028】表中、Meはメチル基、 tBuはt−ブチル
基、Phはフェニル基、Arは置換フェニル基、(m)Me はm
−位にメチル基を有すること、PNZ はp−ニトロベンジ
ルオキシカルボニル基、m-CH3:m位にメチル基を有する
ことを示す。
In the table, Me is a methyl group, t Bu is a t-butyl group, Ph is a phenyl group, Ar is a substituted phenyl group, and (m) Me is m.
- position to have a methyl group in, PNZ the p- nitrobenzyloxycarbonyl group, m-CH 3: shows that with m-position to the methyl group.

【0029】上記表中、好適な化合物としては、1−
1,1−2,1−3,1−6,1−16,1−26,1
−27,1−28,1−29,1−30,1−31,1
−37,1−38,1−39,1−40,1−42,1
−55,1−56,1−59,1−60,1−63,1
−66,1−68,1−69,1−70,1−71,1
−75,2−3,2−4,2−5,2−8,2−21,
2−25,2−46,2−47,2−48,2−49,
2−50,2−51,2−61,2−63,2−65,
2−69,2−70,2−71,2−72,2−76,
2−84,2−85,2−86,2−87,2−88,
2−89,2−92,2−94及び2−96であり、さ
らに好適には、1−1,1−2,1−3,1−6,1−
16,1−26,1−27,1−28,1−29,1−
30,1−31,1−40,1−56,1−60,1−
63,1−66,1−68,1−69,1−70,1−
71,2−3,2−4,2−5,2−8,2−21,2
−25,2−61,2−63,2−65,2−69,2
−70,2−71及び2−72であり、最も好適には、
1−2,1−3,1−56,1−60,1−67,2−
3,2−4,2−5,2−8である。本発明の化合物は
種々の方法により調製することができ、その一般的技法
はこの種の化合物の調製に関する分野で公知である。
In the above table, preferred compounds include 1-
1, 1-2, 1-3, 1-6, 1-16, 1-26, 1
-27, 1-28, 1-29, 1-30, 1-31, 1
-37, 1-38, 1-39, 1-40, 1-42, 1
-55, 1-56, 1-59, 1-60, 1-63, 1
-66,1-68,1-69,1-70,1-71,1
-75,2-3,2-4,2-5,2-8,2-21,
2-25, 2-46, 2-47, 2-48, 2-49,
2-50, 2-51, 2-61, 2-63, 2-65,
2-69, 2-70, 2-71, 2-72, 2-76,
2-84, 2-85, 2-86, 2-87, 2-88,
2-89, 2-92, 2-94 and 2-96, more preferably 1-1, 1-2, 1-3, 1-6, 1-
16, 1-26, 1-27, 1-28, 1-29, 1-
30, 1-31, 1-40, 1-56, 1-60, 1-
63,1-66,1-68,1-69,1-70,1-
71,2-3,2-4,2-5,2-8,2-21,2
-25,2-61,2-63,2-65,2-69,2
-70, 2-71 and 2-72, most preferably
1-2, 1-3, 1-56, 1-60, 1-67, 2-
3,2-4,2-5,2-8. The compounds of the present invention can be prepared by a variety of methods, the general techniques of which are well known in the art for the preparation of compounds of this type.

【0030】例えば、該化合物は、式 (II)For example, the compound has the formula (II)

【0031】[0031]

【化5】 [Chemical 5]

【0032】(式中、R2 、R3 およびZは前述のとお
り、R8 、R9 およびR10は同一又は異なって、各々は
炭素数1〜4個のアルキル基又はフェニル基を表わす)
の化合物を、式 (III)
(In the formula, R 2 , R 3 and Z are as described above, R 8 , R 9 and R 10 are the same or different and each represents an alkyl group having 1 to 4 carbon atoms or a phenyl group.)
A compound of formula (III)

【0033】[0033]

【化6】 [Chemical 6]

【0034】(式中、RおよびR4 は前述のとお
り、R11はアシルオキシ、アルキルスルホニル、アリー
ルスルホニル、アルキルスルフィニル又はアリールスル
フィニル基を表わす)の化合物と反応させることにより
調製される。
It is prepared by reacting a compound of the formula (wherein R 1 and R 4 are as described above, R 11 is an acyloxy, alkylsulfonyl, arylsulfonyl, alkylsulfinyl or arylsulfinyl group).

【0035】より好ましくは、式 (III)の化合物は、式
(IIIa)
More preferably, the compound of formula (III) has the formula
(IIIa)

【0036】[0036]

【化7】 [Chemical 7]

【0037】に示されるような立体配置を有するので、
式(Ia)
Since it has a configuration as shown in,
Formula (Ia)

【0038】[0038]

【化8】 [Chemical 8]

【0039】の化合物が得られる。The compound of ## STR7 ## is obtained.

【0040】R8 、R9 およびR10で示されるアルキル
基の例としては、メチル、エチル、プロピル、イソプロ
ピル、ブチル、sec−ブチルおよびt−ブチル基が挙
げられる。式SiR8 9 10の好ましい基の例として
はt−ブチルジメチルシリル、トリメチルシリル、トリ
エチルシリル、トリイソプロピルシリルおよびt−ブチ
ルジフェニルシリル基が挙げられる。
Examples of the alkyl group represented by R 8 , R 9 and R 10 include methyl, ethyl, propyl, isopropyl, butyl, sec-butyl and t-butyl groups. Examples of preferred groups of formula SiR 8 R 9 R 10 include t-butyldimethylsilyl, trimethylsilyl, triethylsilyl, triisopropylsilyl and t-butyldiphenylsilyl groups.

【0041】R11で示されるアシルオキシ基は、脂肪族
又は芳香族のカルボキシルアシルオキシ基である。脂肪
族アシルオキシ基の場合、これらは好ましくは1〜6
個、より好ましくは2〜4個の炭素原子を有し、アルカ
ノイルオキシ、ハロアルカノイルオキシ又はアルケノイ
ルオキシ基であり、アルカノイルオキシ基が好ましい。
このような基の例としは、アセトキシ、プロピオニルオ
キシおよびブチリルオキシ基が挙げられる。芳香族アシ
ルオキシ基の場合、アリールカルボニルオキシ基であ
り、アリール部分は前記定義および例示のとおりであ
る。好ましい基は、ベンゾイルオキシ基である。アルキ
ルスルホニルおよびアルキルスルフィニル基の場合、ア
ルキル部分は、1〜6個、好ましくは1〜4個の炭素原
子を有し、このような基のアルキル部分の例としては、
メチル、エチル、プロピルおよびイソプロピル基が挙げ
られる。アリールスルホニルおよびアリールスルフィニ
ル基の場合は、アリール部分は前記定義および例示のと
おりであってよく、このような基のアリール部分の例と
してはフェニルおよびp−トリル基が挙げられる。好ま
しくは、R11は、アセトキシ、ベンゾイルオキシ、フェ
ニルスルホニル、フェニルスルフィニル、トリルスルフ
ィニル又はメチルスルフィニル基である。
The acyloxy group represented by R 11 is an aliphatic or aromatic carboxylacyloxy group. In the case of aliphatic acyloxy groups, these are preferably 1-6.
An alkanoyloxy, haloalkanoyloxy or alkenoyloxy group, each having 2 to 4 carbon atoms, and preferably an alkanoyloxy group.
Examples of such groups include acetoxy, propionyloxy and butyryloxy groups. In the case of an aromatic acyloxy group, it is an arylcarbonyloxy group, and the aryl moiety is as defined and exemplified above. A preferred group is the benzoyloxy group. In the case of alkylsulfonyl and alkylsulfinyl groups, the alkyl moiety has 1 to 6, preferably 1 to 4 carbon atoms, examples of alkyl moieties of such groups include:
Included are methyl, ethyl, propyl and isopropyl groups. In the case of arylsulfonyl and arylsulfinyl groups, the aryl moiety may be as defined and exemplified above, examples of aryl moieties of such groups include phenyl and p-tolyl groups. Preferably R 11 is an acetoxy, benzoyloxy, phenylsulfonyl, phenylsulfinyl, tolylsulfinyl or methylsulfinyl group.

【0042】この反応において、式 (II) のシリルエノ
ールエーテルを式(III) のアゼチジノン誘導体と反応さ
せる。この反応は、通常、好ましくは溶媒およびルイス
酸の存在下に起こる。
In this reaction, a silyl enol ether of formula (II) is reacted with an azetidinone derivative of formula (III). The reaction usually takes place preferably in the presence of a solvent and a Lewis acid.

【0043】該反応において用いられるルイス酸の例と
しては、塩化亜鉛、臭化亜鉛、ヨウ化亜鉛および三フッ
化ホウ素エーテラートが挙げられる。このうち塩化亜鉛
又はヨウ化亜鉛が好ましい。
Examples of Lewis acids used in the reaction include zinc chloride, zinc bromide, zinc iodide and boron trifluoride etherate. Of these, zinc chloride or zinc iodide is preferable.

【0044】該反応は通常好ましくは溶媒の存在下で起
こる。用いる溶媒が、反応あるいは用いる試薬に悪影響
を及ぼさず、試薬を最低ある程度溶解できるならば、そ
の性質には特に制限はない。適した溶媒の例としては、
ハロゲン化炭化水素、特にハロゲン化脂肪族炭化水素、
例えば塩化メチレン、クロロホルムおよび1,2−ジク
ロロエタン;エーテル、例えばテトラヒドロフランおよ
び1,2−ジメトキシエタン;およびニトリル、例えば
アセトニトリルが挙げられる。このうち、塩化メチレ
ン、クロロホルムまたは1,2−ジクロロエタンが好ま
しくは用いられる。
The reaction usually takes place preferably in the presence of a solvent. If the solvent used does not adversely affect the reaction or the reagent used and can dissolve the reagent at least to some extent, its properties are not particularly limited. Examples of suitable solvents include
Halogenated hydrocarbons, especially halogenated aliphatic hydrocarbons,
Examples include methylene chloride, chloroform and 1,2-dichloroethane; ethers such as tetrahydrofuran and 1,2-dimethoxyethane; and nitrites such as acetonitrile. Of these, methylene chloride, chloroform or 1,2-dichloroethane is preferably used.

【0045】該反応は広範囲に及ぶ温度にわたり行うこ
とができ、厳密な反応温度は本発明においては重要でな
い。一般に、反応を−10℃〜70℃、より好ましくは
10℃〜50℃の温度にて行うのが便利である。反応に
要する時間も、多くの要因、特に反応温度および用いる
試薬および溶媒の性質により広範囲に変化する。しか
し、すでに概要を記載したような好ましい条件下で反応
が行われるならば、10分〜24時間の期間で通常十分
である。
The reaction can be carried out over a wide range of temperatures and the exact reaction temperature is not critical to the invention. In general, it is convenient to carry out the reaction at a temperature of -10 ° C to 70 ° C, more preferably 10 ° C to 50 ° C. The time required for the reaction also varies widely depending on many factors, notably the reaction temperature and the nature of the reagents and solvents used. However, if the reaction is carried out under the preferred conditions as outlined above, a period of 10 minutes to 24 hours is usually sufficient.

【0046】このようにして得られる式(I)の化合物
は通常のいかなる方法でも反応混合物から回収できる。
例えば、適当な回収方法の一例としては、反応混合物に
塩化メチレン又は酢酸エチルなどの溶媒を添加し、分離
し、有機層を水で洗浄し、最後に薄層クロマトグラフィ
ーまたはシリカゲルを通したフラッシュクロマトグラフ
ィーなどの適切な手段で所望の化合物を分離するか又は
結晶化又は再結晶などの手段により精製する。
The compound of formula (I) thus obtained can be recovered from the reaction mixture by any conventional method.
For example, as an example of a suitable recovery method, a solvent such as methylene chloride or ethyl acetate is added to the reaction mixture, the mixture is separated, the organic layer is washed with water, and finally, thin layer chromatography or flash chromatography through silica gel is performed. The desired compound is isolated by a suitable means such as chromatography or purified by means such as crystallization or recrystallization.

【0047】この反応において出発物質として用いる式
(II)のシリルエノールエーテルは式(IV): R2 CH2 COZR3 (IV) (式中、R2 、R3 およびZは前記定義のとおり)の化
合物を式(V): R8 9 10SiW (V) (式中、R8 、R9 およびR10は前記定義のとおり、W
は例えば塩素原子などのハロゲン原子、またはトリフル
オロメタンスルホニルオキシ基などのスルホニルオキシ
基などの脱離基を表わす)の活性シリル化合物と塩基の
存在下に反応させることにより調製することができる。
The formula used as the starting material in this reaction
The silyl enol ether of (II) is a compound of formula (IV): R 2 CH 2 COZR 3 (IV) (wherein R 2 , R 3 and Z are as defined above) is a compound of formula (V): R 8 R 9 R 10 SiW (V) (wherein R 8 , R 9 and R 10 are as defined above)
Represents a halogen atom such as a chlorine atom, or a leaving group such as a sulfonyloxy group such as a trifluoromethanesulfonyloxy group), and can be prepared by reacting in the presence of a base.

【0048】この反応は、通常好ましくは溶媒の存在下
に行われる。反応又は関係する試薬に悪影響を及ぼさ
ず、最低ある程度試薬を溶解できるならば用いる溶媒の
性質に特に制限はない。適した溶媒の例としては、エー
テル、例えばジエチルエーテル、1,2−ジメトキシエ
タンおよびテトラヒドロフラン;および炭化水素、特に
脂肪族炭化水素、例えばヘキサン又はシクロヘキサンが
挙げられ、これらの溶媒のうちいずれか2種以上の混合
物も用いられる。
The reaction is usually and preferably effected in the presence of solvent. There is no particular limitation on the nature of the solvent used as long as it does not adversely affect the reaction or related reagents and can dissolve the reagents to a certain extent. Examples of suitable solvents include ethers such as diethyl ether, 1,2-dimethoxyethane and tetrahydrofuran; and hydrocarbons, especially aliphatic hydrocarbons such as hexane or cyclohexane, any two of these solvents. Mixtures of the above may also be used.

【0049】反応の収率は、1種以上の以下の溶媒を1
種以上の前記溶媒に添加することにより向上できる。こ
のような添加する溶媒の例としては、ヘキサメチルリン
酸トリアミド(HMPA)、N,N−ジメチルホルムア
ミド、N,N−ジメチルアセトアミド、N,N1 −ジメ
チルプロピレン尿素、N−メチルピロリドンおよびN−
メチルピペリドンが挙げられる。
The yield of the reaction may be one or more of the following solvents:
It can be improved by adding to the solvent of one or more kinds. Examples of such a solvent to be added include hexamethylphosphoric triamide (HMPA), N, N-dimethylformamide, N, N-dimethylacetamide, N, N 1 -dimethylpropyleneurea, N-methylpyrrolidone and N-
Methyl piperidone is mentioned.

【0050】本反応において用いられる塩基の例として
は、ジイソプロピルアミン、ヘキサメチルジシラザン、
ジシクロヘキシルアミン又は2,2,6,6−テトラメ
チルピペリジンのリチウム、ナトリウムまたはカリウム
塩が挙げられる。
Examples of the base used in this reaction include diisopropylamine, hexamethyldisilazane,
Mention may be made of the lithium, sodium or potassium salt of dicyclohexylamine or 2,2,6,6-tetramethylpiperidine.

【0051】1種以上の塩基および前記の塩基を添加す
ることにより式 (II) の化合物の収率が向上する場合も
ある。このような塩基の例としては、トリエチルアミン
などの第三アミンが挙げられる。
The addition of one or more bases and the above-mentioned bases may improve the yield of the compound of formula (II). Examples of such bases include tertiary amines such as triethylamine.

【0052】該反応は広範囲に及ぶ温度にわたり行うこ
とができ、厳密な反応温度は本発明においては重要でな
い。一般に、反応を−90℃〜20℃、より好ましくは
−78℃〜−20℃の温度にて行うのが都合よい。反応
に要する時間も、多くの要因、特に反応温度および用い
る試薬および溶媒の性質により広範囲に変化する。しか
し、反応がすでに概要を記載したような好ましい条件下
で行われるならば、5分から4時間、より好ましくは1
0分から30分の期間で通常十分である。
The reaction can be carried out over a wide range of temperatures and the exact reaction temperature is not critical to the invention. In general, it is convenient to carry out the reaction at a temperature of -90 ° C to 20 ° C, more preferably -78 ° C to -20 ° C. The time required for the reaction also varies widely depending on many factors, notably the reaction temperature and the nature of the reagents and solvents used. However, if the reaction is carried out under the preferred conditions as outlined above, 5 minutes to 4 hours, more preferably 1
A period of 0 to 30 minutes is usually sufficient.

【0053】得られた式 (II) の化合物は通常の方法で
反応混合物から回収できる。例えば、反応混合物に水、
炭酸水素ナトリウムの飽和水溶液またはトリエチルアミ
ンを添加し、混合物を有機溶媒で抽出し、次にカラムク
ロマトグラフィーまたは蒸留などの手段により精製する
ことにより収率良く回収できる。
The compound of formula (II) obtained can be recovered from the reaction mixture by conventional methods. For example, water in the reaction mixture,
A saturated aqueous solution of sodium hydrogen carbonate or triethylamine is added, the mixture is extracted with an organic solvent, and then purified by a means such as column chromatography or distillation to recover the product in good yield.

【0054】R3 がフェニル基を表わし、R2 がメチル
基を表わし、Zが硫黄原子を表わす場合、得られる式
(IV)の化合物は置換−フェニルチオプロピオネー
トであり、これは前記反応における出発化合物として用
いることができる。
When R 3 represents a phenyl group, R 2 represents a methyl group and Z represents a sulfur atom, the resulting compound of formula (IV) is a substituted S -phenylthiopropionate, which is It can be used as a starting compound in the reaction.

【0055】これは以下の反応スキームAおよびBに示
すようにして調製される。
It is prepared as shown in Reaction Schemes A and B below.

【0056】[0056]

【化9】 [Chemical 9]

【0057】[0057]

【化10】 [Chemical 10]

【0058】[0058]

【化11】 [Chemical 11]

【0059】[0059]

【化12】 [Chemical 12]

【0060】前記式中、R3a、R5 およびR6 は前記定
義のとおりである。R12はアリール基(前記定義のとお
り)、例えばフェニルまたはトリル基、R13は1〜6個
の炭素原子、好ましくは1〜4個の炭素原子を有する低
級アルキル基、例えばメチルまたはエチル基を表わす。
In the above formula, R 3a , R 5 and R 6 are as defined above. R 12 is an aryl group (as defined above), eg a phenyl or tolyl group, R 13 is a lower alkyl group having 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms, eg a methyl or ethyl group. Represent.

【0061】反応工程表Aにおいて、置換−フェニル
チオプロピオネート、即ち式(IVa)の化合物は、式
(VI)の化合物から調製でき、式(VI)の化合物は
2,21 −ジチオ安息香酸誘導体を塩化チオニルなどの
ハロゲン化剤と反応させることにより容易に得られる。
In Reaction Scheme A, a substituted S -phenylthiopropionate, a compound of formula (IVa) can be prepared from a compound of formula (VI) and a compound of formula (VI) is 2,2 1 -dithio. It is easily obtained by reacting a benzoic acid derivative with a halogenating agent such as thionyl chloride.

【0062】工程A1において、二級アミンR5 6
Hを式(VI)の化合物とトリエチルアミンなどの有機
アミン又は炭酸ナトリウムなどの無機塩基の存在下にて
反応させ、式(VII)の化合物を得る。工程A2におい
て、この式(VII)の化合物を亜鉛などの還元活性を有
する金属の存在下にてプロピオン酸無水物と反応させ
る。
In step A1, the secondary amine R 5 R 6 N
H is reacted with a compound of formula (VI) in the presence of an organic amine such as triethylamine or an inorganic base such as sodium carbonate to give a compound of formula (VII). In step A2, the compound of formula (VII) is reacted with propionic anhydride in the presence of a metal having reducing activity such as zinc.

【0063】あるいは、反応工程表Bにおいて、式(V
III)のチオサリチル酸誘導体を出発物質として用いて式
(IVa)の化合物を調製する。
Alternatively, in the reaction process table B, the formula (V
The compound of formula (IVa) is prepared using the thiosalicylic acid derivative of III) as a starting material.

【0064】この反応工程表の工程B1において、式
(VIII)の化合物を塩化ベンゾイルなどの芳香族ハロゲ
ン化アシルと反応させることにより式(VIII)の化合物
のチオール基を保護し、式(IX)の保護化合物を得る
工程B2において、式(IX)の化合物を2−クロロ−
1−メチルピリジウムヨージド等の脱水縮合剤の存在下
に二級アミンR5 6 NHと反応させて、式(X)のア
ミド化合物を得る。
In step B1 of this reaction scheme, the compound of formula (VIII) is protected with a thiol group of the compound of formula (VIII) by reacting it with an aromatic acyl halide such as benzoyl chloride. In step B2, the compound of formula (IX) is treated with 2-chloro-
In the presence of a dehydrating condensing agent such as 1-methyl-pyridium iodide is reacted with a secondary amine R 5 R 6 NH, give an amide compound of formula (X).

【0065】工程B3において、式(X)の化合物をナ
トリウムメトキシドなどの塩基で処理することにより芳
香族アシル保護基R12COを除去し、式(XI)の化合
物を得る。
In step B3, the aromatic acyl protecting group R 12 CO is removed by treating the compound of formula (X) with a base such as sodium methoxide to give the compound of formula (XI).

【0066】工程B4において、塩基の存在下にプロピ
オニルクロリドまたはプロピオン酸無水物などのプロピ
オン酸の活性誘導体と反応させることにより式(XI)
の化合物のチオール基をプロピオニル化して、式(IV
a)の所望の置換−フェニルチオプロピオネートを得
る。
In step B4, a compound of formula (XI) is prepared by reacting with an active derivative of propionic acid such as propionyl chloride or propionic anhydride in the presence of a base.
Of the compound of formula (IV
The desired substituted S -phenylthiopropionate of a) is obtained.

【0067】あるいは、式(XI)の化合物は、式(X
II)のアントラニル酸誘導体から通常の手段(例えば、
Organic Syntheses Coll.Vol.III,page 809 に開示され
ているとおり)により工程B5およびB6を経て調製す
ることもできる。工程B5において、式(XII)の化合
物をジアゾ化し、次にカリウム−エチルジチオカルボ
ネートと反応させて式(XIII)の化合物を得る。工程B
6において、この式(XIII)の化合物を、水酸化カリウ
ムなどの塩基を用いて加水分解して、式(XI)の化合
物を得る。
Alternatively, the compound of formula (XI) is
II) from the anthranilic acid derivative by conventional means (eg,
(As disclosed in Organic Syntheses Coll. Vol. III, page 809) via steps B5 and B6. In step B5, the compound of formula (XII) is diazotized and then reacted with potassium S -ethyldithiocarbonate to give the compound of formula (XIII). Process B
In 6, the compound of formula (XIII) is hydrolyzed with a base such as potassium hydroxide to give the compound of formula (XI).

【0068】反応工程表Bは、R3 が置換フェニル基、
Yが酸素原子、Zが硫黄原子である式(IV)の化合
物、即ち式(IVa)の化合物の調製法を示す。Yが硫
黄原子またはZが酸素原子である対応する化合物は、以
下の反応工程表CおよびDに示すようにして調製するこ
とができる。
In reaction process table B, R 3 is a substituted phenyl group,
A method for preparing a compound of formula (IV) in which Y is an oxygen atom and Z is a sulfur atom, that is, a compound of formula (IVa) is shown. Corresponding compounds in which Y is a sulfur atom or Z is an oxygen atom can be prepared as shown in Reaction Schemes C and D below.

【0069】前記式中、R3a、R5 およびR6 は前記定
義のとおりであり、Halはハロゲン原子を表わす。
In the above formula, R 3a , R 5 and R 6 are as defined above, and Hal represents a halogen atom.

【0070】反応工程表Cにおいて、式(IVa)の化
合物の2位のアミド基のカルボニル基形成部分をラベッ
ソン試薬または五硫化リンなどのチオール化剤との反応
によりチオカルボニル基に変換する。この反応は当該技
術分野では公知で、一般的で公知の溶媒、反応温度およ
び反応時間を用いて行ってもよい。
In the reaction process table C, the carbonyl group-forming portion of the amide group at the 2-position of the compound of formula (IVa) is converted to a thiocarbonyl group by reaction with a Labesson's reagent or a thiolating agent such as phosphorus pentasulfide. This reaction is known in the art and may be carried out using a general and known solvent, reaction temperature and reaction time.

【0071】反応工程表Dの工程D1において、式(I
Va)の化合物の2位のカルボキシル基を塩化オキサリ
ル、臭化オキサリル、塩化チオニル又は臭化チオニル等
の通常のハロゲン化剤および通常のハロゲン化条件を用
いてハロゲン化、好ましくは塩素化して、式(XVI)
の化合物を得る。この式(XVI)の化合物を次に式R
5 6 NHの二級アミンとトリエチルアミンなどの有機
三級アミン又は炭酸ナトリウムなどの無機塩基の存在下
に反応させて所望の式(XVII)の化合物を得る。
In the step D1 of the reaction process table D, the formula (I
The compound of formula (Va) is halogenated, preferably chlorinated, with a conventional halogenating agent such as oxalyl chloride, oxalyl bromide, thionyl chloride or thionyl bromide and a conventional halogenating condition, and preferably chlorinated the carboxyl group at the 2-position to give a compound of the formula (XVI)
To obtain the compound of This compound of formula (XVI) is then converted to formula R
Reaction with a secondary amine of 5 R 6 NH in the presence of an organic tertiary amine such as triethylamine or an inorganic base such as sodium carbonate provides the desired compound of formula (XVII).

【0072】本発明の式(I)のアゼチジノン誘導体
は、適当な式R14SHのメルカプタン誘導体との反応に
より対応するカルバペネム化合物に容易に変換でき、こ
の反応は、通常の方法(例えば、特開昭60−1976
4号に記載されているとおり)により行って、式(XV
III)の化合物を得る。これを次に通常の方法(例えば特
開昭62−54427号に記載されているとおり)によ
り環化して、以下の反応工程表EおよびE1 に示すよう
に、式(XIX)のカルバペネム誘導体を得る。
The azetidinone derivative of formula (I) of the present invention can be easily converted into the corresponding carbapenem compound by reaction with a suitable mercaptan derivative of formula R 14 SH, which reaction can be carried out in a conventional manner (see, for example 60-1976
(As described in No. 4) and the formula (XV
The compound of III) is obtained. This is then cyclized by a conventional method (for example, as described in JP-A-62-54427) to give a carbapenem derivative of formula (XIX) as shown in the following reaction process tables E and E 1. obtain.

【0073】これらの式中、Z、R1 、R2 、R3 およ
びR4 は前記定義のとおりであり、R14はカルバペネム
誘導体の指定した位置において通常用いられる種類の種
々の有機基を表わす。反応工程表E1 よりわかるよう
に、アゼチジン3位およびR2 で示される基が結合した
炭素での立体配置は保持され、従って、これらの重要な
化合物が都合良く、効率良く製造できる。
In these formulas, Z, R 1 , R 2 , R 3 and R 4 are as defined above, and R 14 represents various organic groups of the type usually used at the designated position of the carbapenem derivative. .. As can be seen from the reaction process table E 1 , the configuration at the carbon to which the azetidine 3-position and the group represented by R 2 are bonded is retained, and therefore these important compounds can be conveniently and efficiently prepared.

【0074】これに対して、前記のアメリカ合衆国特許
明細書第4895939号および第4772683号に
記載されている式(C)の化合物は、反応工程表Eの第
一工程において式R14SHのメルカプタンと容易に反応
せず、従って、式(XVII)の化合物を容易に形成する
ことができないのでこの反応に適さない。一方、T.Shib
ata ら[Tetrahedron Letters,26,4793(1985) ]、C.U.
Kim ら[TetrahedronLetters,28,507 (1987) ]および
A.Martel ら[Can.J.Chem.,66,1537(1988) ]により記
載されてる反応において、所望の2−異性体は、大量
の望ましくない2−異性体との混合物中比較的低い収
率で得られるので、単離するのが困難で費用がかかる。
On the other hand, the compound of formula (C) described in the above-mentioned US Pat. Nos. 4,895,939 and 4,772,683 is the mercaptan of the formula R 14 SH in the first step of Reaction Process Table E. It is not suitable for this reaction because it does not react easily and therefore the compound of formula (XVII) cannot be easily formed. On the other hand, T.Shib
ata et al. [Tetrahedron Letters, 26 , 4793 (1985)], CU
Kim et al. [Tetrahedron Letters, 28 , 507 (1987)] and
In the reaction described by A. Martel et al. [Can. J. Chem., 66 , 1537 (1988)], the desired 2 R -isomer is relatively high in a mixture with large amounts of the undesired 2 S -isomer. It is difficult and expensive to isolate because it is obtained in low yields.

【0075】[0075]

【発明の効果】本発明の化合物(I)のS−フェニルエ
ステル部分を常法(特開昭60-19764号公報)に従って適
当なメルカプタン誘導体RSHで、容易に置換させて化
合物(XVIII)を製造することが可能である。
The S-phenyl ester moiety of the compound (I) of the present invention is easily replaced with a suitable mercaptan derivative RSH according to a conventional method (JP-A-60-19764) to produce a compound (XVIII). It is possible to

【0076】得られた化合物(XVIII)は常法(特
公昭62-54427号公報)に従ってカルバペネム誘導体(X
IX)へ導くことができる。このように本発明化合物
(I)は1β−メチルカルバペネム誘導体(XV)の合成の
有用な中間体である。
The obtained compound (XVIII) is a carbapenem derivative (X) according to the conventional method (Japanese Patent Publication No. 62-54427).
IX). Thus, the compound (I) of the present invention is a useful intermediate in the synthesis of 1β-methylcarbapenem derivative (XV).

【0077】[0077]

【実施例】【Example】

【0078】[0078]

【実施例1】(2R)−2−[(3S,4S)−3−[(R)−1−
(t−ブチルジメチルシリルオキシ)エチル]−2−オ
キソ−4−アゼチジニル]チオプロピオン酸 S−(2
−ジエチルアミノカルボニルフェニル)エステル及びそ
の(2S)・異性体 参考例1で得られたシリルエノールエーテル911mg
(2.40mmol)と(3R,4R)−3−[(R)−1−(t
−ブチルジメチルシリルオキシ)エチル]−4−アセト
キシ−2−アゼチジノン347mg(1.21mmol)の塩化メチ
レン12ml溶液に無水塩化亜鉛330mg(2.42mmol)を加
え、室温で2時間撹拌した。反応液を酢酸エチルで希釈
し、水洗、乾燥した後、溶剤を留去した。残渣をローバ
ーカラム[ヘキサン−酢酸エチル(1:1)]で分離精
製し2S−異性体61mg(10%)と2R−異性体48
7mg(82%)を得た。 mp125〜126.5 ℃(ヘキサン−酢酸エチル)[2S−
異性体];mp130.5 〜132℃(イソプロピルエーテ
ル)[2R−異性体] IRスペクトル(KBr)cm-1 : [2S−異性体]3182,1765,1711,16
29,953,774 [2R−異性体]3086,1762,1700,16
37,965,829 NMRスペクトル(270MHz,CDCl3)δppm : [2S−異性体]0.06(3H,s),0.07(3H,s),0.87(9H,s),
1.05(3H,t,J=7Hz),1.26(3H,d,J=6Hz),1.26(3H,t,J=7H
z),1.28(3H,d,J=7Hz),2.71-2.83(2H,m),3.00-3.21(2H,n
onet-like,J=7Hz),3.35-3.80(2H,broad),3.63(1H,d,J=9
Hz),4.14(1H,quintet,J=6Hz),7.00-7.30(1H,br.s),7.30
-7.35(1H,m),7.42-7.53(3H,m) [2R−異性体]0.08(6H,s),0.87(9H,s),1.03(3H,t,J=
7Hz), 1.21(3H,d,J=6Hz),1.25(3H,t,J=7Hz),1.29(3H,d,
J=7Hz), 2.96-3.15(4H,m),3.20-3.85(2H,broad),3.96(1
H,dd,J=2Hz,4Hz),4.19(1H,quintet,J=6Hz),5.90-6.10(1
H,br.s),7.30-7.35(1H,m),7.41-7.51(3H,m) マススペクトル(m/z) :[2R]−及び[2S]−異性
体,492(M+,C25H40N2O4SSi) 元素分析:C25H40N2O4SSi として 計算値:C,60.94;H,8.18;N,5.69;S,6.51 実測値(2S−異性体):C,60.72;H,8.01;N,5.70;S,6.
57 実測値(2R−異性体):C,60.85;H,8.10;N,5.62;S,6.
50 さらに実施例1と同様の方法によって実施例2〜9まで
の化合物を製造した。
Example 1 (2R) -2-[(3S, 4S) -3-[(R) -1-]
(T-Butyldimethylsilyloxy) ethyl] -2-o
Xo-4-azetidinyl] thiopropionic acid S- (2
-Diethylaminocarbonylphenyl) ester and
(2S) isomer of silyl enol ether obtained in Reference Example 1 911 mg
(2.40 mmol) and (3R, 4R) -3-[(R) -1- (t
-Butyldimethylsilyloxy) ethyl] -4-acetoxy-2-azetidinone (340 mg, 1.21 mmol) in methylene chloride (12 ml) was added with anhydrous zinc chloride (330 mg, 2.42 mmol), and the mixture was stirred at room temperature for 2 hours. The reaction solution was diluted with ethyl acetate, washed with water and dried, and then the solvent was distilled off. The residue was separated and purified on a Rover column [hexane-ethyl acetate (1: 1)] to give 61 mg (10%) of 2S-isomer and 48 of 2R-isomer.
7 mg (82%) were obtained. mp125-126.5 ° C (hexane-ethyl acetate) [2S-
Isomer]; mp130.5-132 ° C (isopropyl ether) [2R-isomer] IR spectrum (KBr) cm -1 : [2S-isomer] 3182, 1765, 1711, 16
29,953,774 [2R-isomer] 3086,1762,1700,16
37,965,829 NMR spectrum (270 MHz, CDCl 3 ) δppm: [2S-isomer] 0.06 (3H, s), 0.07 (3H, s), 0.87 (9H, s),
1.05 (3H, t, J = 7Hz), 1.26 (3H, d, J = 6Hz), 1.26 (3H, t, J = 7H
z), 1.28 (3H, d, J = 7Hz), 2.71-2.83 (2H, m), 3.00-3.21 (2H, n
onet-like, J = 7Hz), 3.35-3.80 (2H, broad), 3.63 (1H, d, J = 9
Hz), 4.14 (1H, quintet, J = 6Hz), 7.00-7.30 (1H, br.s), 7.30
-7.35 (1H, m), 7.42-7.53 (3H, m) [2R-isomer] 0.08 (6H, s), 0.87 (9H, s), 1.03 (3H, t, J =
7Hz), 1.21 (3H, d, J = 6Hz), 1.25 (3H, t, J = 7Hz), 1.29 (3H, d,
J = 7Hz), 2.96-3.15 (4H, m), 3.20-3.85 (2H, broad), 3.96 (1
H, dd, J = 2Hz, 4Hz), 4.19 (1H, quintet, J = 6Hz), 5.90-6.10 (1
H, br.s), 7.30-7.35 (1H, m), 7.41-7.51 (3H, m) mass spectrum (m / z): [2R]-and [2S] -isomers, 492 (M + , C) 25 H 40 N 2 O 4 SSi) Elemental analysis: C 25 H 40 N 2 O 4 SSi Calculated value: C, 60.94; H, 8.18; N, 5.69; S, 6.51 Actual value (2S-isomer): C , 60.72; H, 8.01; N, 5.70; S, 6.
57 Found (2R-isomer): C, 60.85; H, 8.10; N, 5.62; S, 6.
50 Furthermore, the compounds of Examples 2 to 9 were produced by the same method as in Example 1.

【0079】[0079]

【実施例2】(2R)−2−[(3S,4S)−3−[(R)−1−
(t−ブチルジメチルシリルオキシ)エチル]−2−オ
キソ−4−アゼチジニル]チオプロピオン酸 S−(2
−ジメチルアミノカルボニルフェニル)エステル 2R−異性体の収率(%) 79 2Rと2S−異性体の収率比 4.9 結晶形状 針状晶 mp( ℃) 99〜101 再結溶媒 (EtOAc-hex) NMR スペクトルδppm(CDCl3):0.08(6H,s),0.88(9H,s),
1.21(3H,d,J=6Hz), 1.29(3H,d,J=7Hz),2.79(3H,s),2.96
-3.08(2H,m),3.10(3H,s),3.94(1H,dd,J=2.5Hz),4.19(1
H,dq,J=5.6Hz),6.10-6.20(1H,brs),7.31-7.36(1H,m),7.
40-7.70(3H,m)
Example 2 (2R) -2-[(3S, 4S) -3-[(R) -1-]
(T-Butyldimethylsilyloxy) ethyl] -2-o
Xo-4-azetidinyl] thiopropionic acid S- (2
-Dimethylaminocarbonylphenyl ) ester 2R-isomer yield (%) 79 YR and 2S-isomer yield ratio 4.9 Crystal shape Needle crystal mp (° C) 99-101 Reconstituted solvent (EtOAc-hex ) NMR spectrum δ ppm (CDCl 3 ): 0.08 (6H, s), 0.88 (9H, s),
1.21 (3H, d, J = 6Hz), 1.29 (3H, d, J = 7Hz), 2.79 (3H, s), 2.96
-3.08 (2H, m), 3.10 (3H, s), 3.94 (1H, dd, J = 2.5Hz), 4.19 (1
H, dq, J = 5.6Hz), 6.10-6.20 (1H, brs), 7.31-7.36 (1H, m), 7.
40-7.70 (3H, m)

【0080】[0080]

【実施例3】(2R)−2−[(3S,4S)−3−[(R)−1−
(t−ブチルジメチルシリルオキシ)エチル]−2−オ
キソ−4−アゼチジニル]チオプロピオン酸 S−(2
−ジプロピルアミノカルボニルフェニル)エステル 2R−異性体の収率(%) 74 2Rと2S−異性体の収率比 3.5 結晶形状 針状晶 mp( ℃) 112〜113 再結溶媒 (EtOAc-hex) NMR スペクトル δppm(CDCl3) 0.08(6H,s),0.72(3H,t,J=7Hz),0.88(9H,s), 1.00(3H,t,
J=7Hz),1.22(3H,d,J=6Hz),1.20- 1.40(3H,broad),1.46
(2H,sextet,J=7Hz), 1.70(2H,sextet,J=7Hz),2.91-3.06
(2H,m), 3.10-3.80(2H,broad),3.96(2H,dd,J=2.4Hz),4.
19(1H,dq,J=5.6Hz),5.90-6.20(1H,brs), 7.29-7.35(1H,
m),7.40-7.51(3H,m)
Third Embodiment (2R) -2-[(3S, 4S) -3-[(R) -1-]
(T-Butyldimethylsilyloxy) ethyl] -2-o
Xo-4-azetidinyl] thiopropionic acid S- (2
-Dipropylaminocarbonylphenyl ) ester Yield of 2R-isomer (%) 74 Yield ratio of 2R and 2S-isomer 3.5 Crystal shape Needle mp (° C) 112-113 Reconstituted solvent (EtOAc- hex) NMR spectrum δppm (CDCl 3 ) 0.08 (6H, s), 0.72 (3H, t, J = 7Hz), 0.88 (9H, s), 1.00 (3H, t,
J = 7Hz), 1.22 (3H, d, J = 6Hz), 1.20-1.40 (3H, broad), 1.46
(2H, sextet, J = 7Hz), 1.70 (2H, sextet, J = 7Hz), 2.91-3.06
(2H, m), 3.10-3.80 (2H, broad), 3.96 (2H, dd, J = 2.4Hz), 4.
19 (1H, dq, J = 5.6Hz), 5.90-6.20 (1H, brs), 7.29-7.35 (1H,
m), 7.40-7.51 (3H, m)

【0081】[0081]

【実施例4】(2R)−2−[(3S,4S)−3−[(R)−1−
(t−ブチルジメチルシリルオキシ)エチル]−2−オ
キソ−4−アゼチジニル]チオプロピオン酸 S−(2
−ジイソブチルアミノカルボニルフェニル)エステル 2R−異性体の収率(%) 70 2Rと2S−異性体の収率比 4.6 結晶形状 針状晶 mp( ℃) 144〜146 再結溶媒 (EtOAc-hex) NMR スペクトル δppm(CDCl3) 0.08(6H,s),0.74(6H,d,J=7Hz),0.87(9H,s), 1.02(6H,d,
J=7Hz),1.21(3H,d,J=6Hz),1.20- 1.40(3H,broad),1.81
(1H,Septet,J=7Hz), 2.12(1H,Septet,J=7Hz),2.80-3.06
(4H,m), 3.20-3.57(2H,broad),3.92-4.05(1H,brs), 4.
13-4.28(1H,broad),5.95-6.15(1H,broad),7.29-7.35(1
H,m),7.42-7.50(3H,m)
Example 4 (2R) -2-[(3S, 4S) -3-[(R) -1-]
(T-Butyldimethylsilyloxy) ethyl] -2-o
Xo-4-azetidinyl] thiopropionic acid S- (2
-Diisobutylaminocarbonylphenyl ) ester 2R-isomer yield (%) 70 2R and 2S-isomer yield ratio 4.6 Crystal shape Needle crystal mp (° C) 144-146 Reconstituted solvent (EtOAc-hex ) NMR spectrum δppm (CDCl 3 ) 0.08 (6H, s), 0.74 (6H, d, J = 7Hz), 0.87 (9H, s), 1.02 (6H, d,
J = 7Hz), 1.21 (3H, d, J = 6Hz), 1.20-1.40 (3H, broad), 1.81
(1H, Septet, J = 7Hz), 2.12 (1H, Septet, J = 7Hz), 2.80-3.06
(4H, m), 3.20-3.57 (2H, broad), 3.92-4.05 (1H, brs), 4.
13-4.28 (1H, broad), 5.95-6.15 (1H, broad), 7.29-7.35 (1
H, m), 7.42-7.50 (3H, m)

【0082】[0082]

【実施例5】(2R)−2−[(3S,4S)−3−[(R)−1−
(t−ブチルジメチルシリルオキシ)エチル]−2−オ
キソ−4−アゼチジニル]チオプロピオン酸 S−(2
−N、N−メチルフェニルアミノカルボニルフェニル)
エステル 2R−異性体の収率(%) 64 2Rと2S−異性体の収率比 2.6 結晶形状 針状晶 mp( ℃) 158〜159.5 再結溶媒 (EtOAc-hex) NMR スペクトル δppm(CDCl3) 0.08,0.09(6H,eachS),0.88(9H,m),1.23(3H, d,J=6Hz),
1.34(3H,d,J=7Hz),3.01-3.12(2H, m),3.49(3H,s),4.00-
4.08(1H,brs),4.20(1H,dq,J=6.6Hz),6.05-6.20(1H,br
s),6.95-7.63 (9H,m)
Fifth Embodiment (2R) -2-[(3S, 4S) -3-[(R) -1-]
(T-Butyldimethylsilyloxy) ethyl] -2-o
Xo-4-azetidinyl] thiopropionic acid S- (2
-N, N-methylphenylaminocarbonylphenyl)
Yield (%) of ester 2R-isomer 64 Yield ratio of 2R and 2S-isomer 2.6 Crystal shape Needle crystal mp (° C) 158-159.5 Recrystallization solvent (EtOAc-hex) NMR spectrum δppm (CDCl 3 ) 0.08,0.09 (6H, eachS), 0.88 (9H, m), 1.23 (3H, d, J = 6Hz),
1.34 (3H, d, J = 7Hz), 3.01-3.12 (2H, m), 3.49 (3H, s), 4.00-
4.08 (1H, brs), 4.20 (1H, dq, J = 6.6Hz), 6.05-6.20 (1H, br
s), 6.95-7.63 (9H, m)

【0083】[0083]

【実施例6】(2R)−2−[(3S,4S)−3−[(R)−1−
(t−ブチルジメチルシリルオキシ)エチル]−2−オ
キソ−4−アゼチジニル]チオプロピオン酸 S−(2
−ピロリジノカルボニルフェニル)エステル 2R−異性体の収率(%) 85 2Rと2S−異性体の収率比 7.1 結晶形状 泡状物質 NMR スペクトル δppm(CDCl3) 0.08(6H,s),0.88(9H,s),1.21(3H,d,J=6Hz), 1.29(3H,d,
J=7Hz),1.75-2.00(4H,m),2.95- 3.06(2H,m),3.18(2H,t,
J=7Hz),3.60(2H,t,J=7Hz),3.96(1H,dd,J=2.4Hz),4.20(1
H,dq,J= 5.6Hz),6.10-6.25(1H,brs),7.37-7.53(4H,m)
Sixth Embodiment (2R) -2-[(3S, 4S) -3-[(R) -1-]
(T-Butyldimethylsilyloxy) ethyl] -2-o
Xo-4-azetidinyl] thiopropionic acid S- (2
-Pyrrolidinocarbonylphenyl ) ester 2R-isomer yield (%) 85 2R and 2S-isomer yield ratio 7.1 Crystal shape foam NMR spectrum δppm (CDCl 3 ) 0.08 (6H, s), 0.88 (9H, s), 1.21 (3H, d, J = 6Hz), 1.29 (3H, d,
J = 7Hz), 1.75-2.00 (4H, m), 2.95-3.06 (2H, m), 3.18 (2H, t,
J = 7Hz), 3.60 (2H, t, J = 7Hz), 3.96 (1H, dd, J = 2.4Hz), 4.20 (1
H, dq, J = 5.6Hz), 6.10-6.25 (1H, brs), 7.37-7.53 (4H, m)

【0084】[0084]

【実施例7】(2R)−2−[(3S,4S)−3−[(R)−1−
(t−ブチルジメチルシリルオキシ)エチル]−2−オ
キソ−4−アゼチジニル]チオプロピオン酸 S−(2
−ピペリジノカルボニルフェニル)エステル 2R−異性体の収率(%) 75 2Rと2S−異性体の収率比 4.8 結晶形状 ガラス状物質 NMR スペクトル δppm(CDCl3) 0.07,0.08(6H,each s),0.87,0.88(9H,each s),1.16-1.
25(3H,m),1.28,1.33(3H,each d, J=7Hz),1.37-1.52(2H,
broad),1.54-1.77(4H,broad),2.95-3.26(4H,m),3.47-3.
60(1H, broad),3.80-3.95(1H,broad),3.97(1H,dd,J=2.4
Hz),4.12-4.26(1H,broad),6.00-6.16(1H,broad),7.26-
7.52(4H,m)
Example 7 (2R) -2-[(3S, 4S) -3-[(R) -1-]
(T-Butyldimethylsilyloxy) ethyl] -2-o
Xo-4-azetidinyl] thiopropionic acid S- (2
- piperidinocarbonyl phenyl) ester 2R- isomer yield (%) 75 2R and 2S- isomers of the yield ratio 4.8 crystalline form glassy material NMR spectrum δppm (CDCl 3) 0.07,0.08 (6H , each s), 0.87,0.88 (9H, each s), 1.16-1.
25 (3H, m), 1.28,1.33 (3H, each d, J = 7Hz), 1.37-1.52 (2H,
broad), 1.54-1.77 (4H, broad), 2.95-3.26 (4H, m), 3.47-3.
60 (1H, broad), 3.80-3.95 (1H, broad), 3.97 (1H, dd, J = 2.4
Hz), 4.12-4.26 (1H, broad), 6.00-6.16 (1H, broad), 7.26-
7.52 (4H, m)

【0085】[0085]

【実施例8】(2R)−2−[(3S,4S)−3−[(R)−1−
(t−ブチルジメチルシリルオキシ)エチル]−2−オ
キソ−4−アゼチジニル]チオプロピオン酸 S−(2
−モルホリノカルボニルフェニル)エステル 2R−異性体の収率(%) 83 2Rと2S−異性体の収率比 7.9 結晶形状 ガラス状物質 NMR スペクトル δppm(CDCl3) 0.08(6H,s),0.88(9H,s),1.21(3H,d,J=7Hz), 1.22-1.38
(3H,m),2.97-3.08(2H,m),3.12- 3.32(2H,m),3.50-3.60
(2H,m),3.70-3.84(4H,broad),3.93-4.01(1H,brs),4.19
(1H,dq,J= 5.5Hz),5.90-6.10(1H,broad),7.20-7.38(1H,
m),7.42-7.55(3H,m)
Example 8 (2R) -2-[(3S, 4S) -3-[(R) -1-]
(T-Butyldimethylsilyloxy) ethyl] -2-o
Xo-4-azetidinyl] thiopropionic acid S- (2
- morpholinocarbonyl phenyl) ester 2R- isomer yield (%) 83 2R and 2S- isomers yield 7.9 crystalline form glassy material NMR spectrum δppm (CDCl 3) 0.08 (6H , s), 0.88 (9H, s), 1.21 (3H, d, J = 7Hz), 1.22-1.38
(3H, m), 2.97-3.08 (2H, m), 3.12-3.32 (2H, m), 3.50-3.60
(2H, m), 3.70-3.84 (4H, broad), 3.93-4.01 (1H, brs), 4.19
(1H, dq, J = 5.5Hz), 5.90-6.10 (1H, broad), 7.20-7.38 (1H,
m), 7.42-7.55 (3H, m)

【0086】[0086]

【実施例9】(2R)−2−[(3S,4S)−3−[(R)−1−
(t−ブチルジメチルシリルオキシ)エチル]−2−オ
キソ−4−アゼチジニル]チオプロピオン酸 S−(2
−(2H−1、3、4、5、6、7−ヘキサヒドロアゼ
ピノ)カルボニルフェニル)エステル 2R−異性体の収率(%) 87 2Rと2S−異性体の収率比 9.5 結晶形状 ガラス状物質 NMR スペクトル δppm(CDCl3) 0.08(6H,s),0.88(9H,s),1.22(3H,d,J=6Hz), 1.20-1.40
(3H,broad),1.50-1.96(8H,broad),2.97-3.10(2H,m),3.0
6-3.32(2H,broad),3.40-3.90(2H,broad),3.96(1H,dd,J=
2.4Hz),4.20(1H,dq,J=6.6Hz),6.05-6.25(1H,broad),7.3
0-7.37(1H,m),7.42-7.52(3H,m)
Example 9 (2R) -2-[(3S, 4S) -3-[(R) -1-]
(T-Butyldimethylsilyloxy) ethyl] -2-o
Xo-4-azetidinyl] thiopropionic acid S- (2
-(2H-1,3,4,5,6,7-hexahydroase
Yield of pino ) carbonylphenyl) ester 2R-isomer (%) 87 Yield ratio of 2R and 2S-isomer 9.5 Crystal shape Glassy substance NMR spectrum δppm (CDCl 3 ) 0.08 (6H, s), 0.88 (9H, s), 1.22 (3H, d, J = 6Hz), 1.20-1.40
(3H, broad), 1.50-1.96 (8H, broad), 2.97-3.10 (2H, m), 3.0
6-3.32 (2H, broad), 3.40-3.90 (2H, broad), 3.96 (1H, dd, J =
2.4Hz), 4.20 (1H, dq, J = 6.6Hz), 6.05-6.25 (1H, broad), 7.3
0-7.37 (1H, m), 7.42-7.52 (3H, m)

【0087】[0087]

【実施例10】(2R)−2−[(3S,4S)−3−[(R)−1−
(t−ブチルジメチルシリルオキシ)エチル]−2−オ
キソ−4−アゼチジニル]チオプロピオン酸 S−(2
−ジエチルアミノカルボニル−6−フェニル)エステル 2R−異性体の収率(%) 88 2Rと2S−異性体の収率比 12.3 結晶形状 針状晶 mp( ℃) 150-150.5 再結溶媒 (i-Pr2O) NMR スペクトルδppm(CDCl3):0.06(3H,s),0.86(9/2H,
s),0.89(9/2H,s),1.02(3H,t,J=7Hz), 1.19-1.29(7.5H,
m),1.35(1.5H,d,J=7Hz),2.35(3H,s),2.92-3.16(4H,m),
3.28-3.41(1H,m),3.74(1H,dq,J=14and7Hz),3.95-4.00(1
H,m),4.17(1H,quitet,J=6Hz),6.00-6.30(1H,brs),7.14
(1H,dd,J=3and6Hz),7.34-7.41(2H,m)
Example 10 (2R) -2-[(3S, 4S) -3-[(R) -1-]
(T-Butyldimethylsilyloxy) ethyl] -2-o
Xo-4-azetidinyl] thiopropionic acid S- (2
-Diethylaminocarbonyl-6-phenyl) ester 2R-isomer yield (%) 88 2R and 2S-isomer yield ratio 12.3 Crystal shape Needle crystal mp (° C) 150-150.5 Reconstituted solvent (i -Pr 2 O) NMR spectrum δppm (CDCl 3 ): 0.06 (3H, s), 0.86 (9 / 2H,
s), 0.89 (9 / 2H, s), 1.02 (3H, t, J = 7Hz), 1.19-1.29 (7.5H,
m), 1.35 (1.5H, d, J = 7Hz), 2.35 (3H, s), 2.92-3.16 (4H, m),
3.28-3.41 (1H, m), 3.74 (1H, dq, J = 14and7Hz), 3.95-4.00 (1
H, m), 4.17 (1H, quitet, J = 6Hz), 6.00-6.30 (1H, brs), 7.14
(1H, dd, J = 3and6Hz), 7.34-7.41 (2H, m)

【0088】[0088]

【実施例11】(2R)−2−[(3S,4S)−3−[(R)−1−
(t−ブチルジメチルシリルオキシ)エチル]−2−オ
キソ−4−アゼチジニル]チオプロピオン酸 S−(2
−ジエチルアミノチオカルボニルフェニル)エステル 2R−異性体の収率(%) 81 2Rと2S−異性体の収率比 4.8 結晶形状 針状晶 mp( ℃) 163-165 再結溶媒 (EtOAc-hex) NMR スペクトルδppm(CDCl3):0.09(6H,s),0.89(9H,s),
1.09(3H,t,J=7Hz), 1.22(3H,d,J=6Hz),1.26(3H,dJ=7H
z),1.38(3H,t,J=7Hz),2.96-3.06(2H,m),3.20(1H,dq,J=1
4and7Hz),3.36(1H,dq,J=14and7Hz),3.97(1H,dd,J=2and5
Hz),4.20(1H,dq,J=5,6Hz),4.46(1H,dq,J=14and7Hz),7.2
2-7.26(1H,m),7.33-7.46(3H,m)
Example 11 (2R) -2-[(3S, 4S) -3-[(R) -1-]
(T-Butyldimethylsilyloxy) ethyl] -2-o
Xo-4-azetidinyl] thiopropionic acid S- (2
-Diethylaminothiocarbonylphenyl ) ester Yield of 2R-isomer (%) 81 Yield ratio of 2R and 2S-isomer 4.8 Crystal shape Needle mp (° C) 163-165 Reconstituted solvent (EtOAc-hex ) NMR spectrum δ ppm (CDCl 3 ): 0.09 (6H, s), 0.89 (9H, s),
1.09 (3H, t, J = 7Hz), 1.22 (3H, d, J = 6Hz), 1.26 (3H, dJ = 7H
z), 1.38 (3H, t, J = 7Hz), 2.96-3.06 (2H, m), 3.20 (1H, dq, J = 1
4and7Hz), 3.36 (1H, dq, J = 14and7Hz), 3.97 (1H, dd, J = 2and5
Hz), 4.20 (1H, dq, J = 5,6Hz), 4.46 (1H, dq, J = 14and7Hz), 7.2
2-7.26 (1H, m), 7.33-7.46 (3H, m)

【0089】[0089]

【実施例12】(2R)−2−[(3S,4S)−3−[(R)−1−
(t−ブチルジメチルシリルオキシ)エチル]−2−オ
キソ−4−アゼチジニル]プロピオン酸 S−(2−ジ
エチルアミノカルボニルフェニル)エステル 2R−異性体の収率(%) 61 2Rと2S−異性体の収率比 6.8 結晶形状 ガラス状物質 NMR スペクトルδppm(CDCl3):0.09(6H,s),0.88(9H,s),
1.10(3H,t,J=7Hz), 1.22(3H,t,J=7Hz),1.25(3H,dJ=6H
z),1.32(3H,d,J=7Hz),2.95(1H,dq,J=4and7Hz),3.00(1H,
d,J=6Hz),3.22(2H,q,J=7Hz),3.42-3.63(1H,m),4.08-4.1
6(1H,m),4.18(1H,quintet,J=6Hz),6.45(1H,brs),7.17(1
H,d,J=8Hz),7.26-7.28(2H,m),7.38-7.43(1H,m)
Twelfth Embodiment (2R) -2-[(3S, 4S) -3-[(R) -1-]
(T-Butyldimethylsilyloxy) ethyl] -2-o
Xo-4-azetidinyl] propionic acid S- (2-di
Yield of ethylaminocarbonylphenyl) ester 2R-isomer (%) 61 Yield ratio of 2R and 2S-isomer 6.8 Crystal shape NMR spectrum of glassy substance δppm (CDCl 3 ): 0.09 (6H, s), 0.88 (9H, s),
1.10 (3H, t, J = 7Hz), 1.22 (3H, t, J = 7Hz), 1.25 (3H, dJ = 6H
z), 1.32 (3H, d, J = 7Hz), 2.95 (1H, dq, J = 4and7Hz), 3.00 (1H,
d, J = 6Hz), 3.22 (2H, q, J = 7Hz), 3.42-3.63 (1H, m), 4.08-4.1
6 (1H, m), 4.18 (1H, quintet, J = 6Hz), 6.45 (1H, brs), 7.17 (1
H, d, J = 8Hz), 7.26-7.28 (2H, m), 7.38-7.43 (1H, m)

【0090】[0090]

【参考例1】Z(0)−1−t−ブチルジメチルシリルオキシ−1−
(2−ジエチルアミノカルボニル)フェニルチオ−1−
プロペン及びそのE(O)−異性体 参考例10で得られた化合物729mg(2.75mmol)、 t−
ブチルジメチルシリルクロリド832mg(5.52mmol)、ヘ
キサメチルリン酸トリアミド621mg(3.47mmol)のテト
ラヒドロフラン6ml溶液を−78℃に冷却しこれにリチ
ウムビス(トリメチルシリル)アミド1.0 Mテトラヒド
ロフラン溶液3.0ml(3.0mmol)を7分間で滴下した。同温
度で10分間撹拌した後、飽和重ソウ水2mlを加え反応
を終結させた。反応混合物にヘキサンを加えた。有機層
をとりこれを水洗し、テトラヒドロフラン及びヘキサメ
チルリン酸トリアミドを除去した。溶剤を留去して得ら
れる残渣をアルミナ20gを用いるカラムクロマトグラ
フィーに付し、塩化メチレン−ヘキサン(1:1)で溶
出し、無色の油状物質として標記化合物922mg(88
%)を得た。NMR スペクトル(270MHz)よりそれはZ
(O)及びE(O)−異性体の混合物でその比は4:1
であった。 NMR スペクトル(270Mz,CDCl3) δppm :,0.10(1.2H,s),
0.11(4.8H,s),0.80(7.2H,s),0.89(1.8H,s),1.07(3H,t,J
=7Hz),1.27(3H,t,J=7Hz),1.70(0.8H,d,J=7Hz),1.78(0.2
H,d,J=7Hz),3.16(1.6H,q,J=7Hz),3.18(0.4H,q,J=7Hz),
3.46-3.65(2H,broad),5.35(1H,q,J=7Hz),7.11-7.20(2H,
m),7.22-7.32(1H,m),7.37-7.45(1H,m) さらに参考例1と同様の方法に従って参考例2〜9の化
合物を製造した。
Reference Example 1 Z (0) -1-t-butyldimethylsilyloxy-1-
(2-Diethylaminocarbonyl) phenylthio-1-
Propene and its E (O) -isomer 729 mg (2.75 mmol) of the compound obtained in Reference Example 10, t-
A solution of 832 mg (5.52 mmol) of butyldimethylsilyl chloride and 621 mg (3.47 mmol) of hexamethylphosphoric triamide in 6 ml of tetrahydrofuran was cooled to −78 ° C., and 3.0 ml (3.0 mmol) of a 1.0 M solution of lithium bis (trimethylsilyl) amide in tetrahydrofuran was added thereto. It dripped in 7 minutes. After stirring for 10 minutes at the same temperature, 2 ml of saturated sodium bicarbonate water was added to terminate the reaction. Hexane was added to the reaction mixture. The organic layer was taken and washed with water to remove tetrahydrofuran and hexamethylphosphoric triamide. The residue obtained by distilling off the solvent was subjected to column chromatography using 20 g of alumina and eluted with methylene chloride-hexane (1: 1) to give 922 mg (88) of the title compound as a colorless oily substance.
%) Was obtained. From NMR spectrum (270MHz) it is Z
A mixture of (O) and E (O) -isomers in a ratio of 4: 1
Met. NMR spectrum (270 Mz, CDCl 3 ) δppm :, 0.10 (1.2H, s),
0.11 (4.8H, s), 0.80 (7.2H, s), 0.89 (1.8H, s), 1.07 (3H, t, J
= 7Hz), 1.27 (3H, t, J = 7Hz), 1.70 (0.8H, d, J = 7Hz), 1.78 (0.2
H, d, J = 7Hz), 3.16 (1.6H, q, J = 7Hz), 3.18 (0.4H, q, J = 7Hz),
3.46-3.65 (2H, broad), 5.35 (1H, q, J = 7Hz), 7.11-7.20 (2H,
m), 7.22-7.32 (1H, m), 7.37-7.45 (1H, m) Further, the compounds of Reference Examples 2 to 9 were produced in the same manner as in Reference Example 1.

【0091】[0091]

【参考例2】Z(0)−1−t−ブチルジメチルシリルオキシ−1−
(2−ジメチルアミノカルボニル)フェニルチオ−1−
プロペン及びそのE(O)−異性体 Z(O)- 及びE(O)- 異性体比 4 NMR スペクトル δppm 0.10(1.2H,s),0.11(4.8H,s),0.79(1.8H,s),0.89(7.2H,
s),1.70 (2.4H,d,J=7Hz),1.78(0.6H,d,J=7Hz),2.88(3H,
s),3.12(3H,s),5.33(0.2H,q,J=7Hz),5.35(0.8H,q,J=7H
z), 7.15-7.20(2H,m),7.24-7.33 (1H,m),7.40-7.47(1
H,m)
Reference Example 2 Z (0) -1-t-butyldimethylsilyloxy-1-
(2-Dimethylaminocarbonyl) phenylthio-1-
Propene and its E (O) -isomer Z (O)-and E (O)-isomer ratio 4 NMR spectrum δppm 0.10 (1.2H, s), 0.11 (4.8H, s), 0.79 (1.8H, s) ), 0.89 (7.2H,
s), 1.70 (2.4H, d, J = 7Hz), 1.78 (0.6H, d, J = 7Hz), 2.88 (3H,
s), 3.12 (3H, s), 5.33 (0.2H, q, J = 7Hz), 5.35 (0.8H, q, J = 7H
z), 7.15-7.20 (2H, m), 7.24-7.33 (1H, m), 7.40-7.47 (1
H, m)

【0092】[0092]

【参考例3】Z(0)−1−t−ブチルジメチルシリルオキシ−1−
(2−ジプロピルアミノカルボニル)フェニルチオ−1
−プロペン及びそのE(O)−異性体 Z(O)- 及びE(O)- 異性体比 2 NMR スペクトル δppm 0.10(2H,s),0.11(4H,s),0.73(3H,t,J=7Hz),0.81(3H,s),
0.89(6H, s),1.00(3H,t,J=7Hz),1.43-1.60(2H,m),1.62-
1.80(2H,m),1.70(2H,d,J=7Hz),1.77(1H,d,J=7Hz),3.05
(1.3H,t,J=7Hz),3.08(0.7H,t,J= 7Hz),3.46-3.60(2H,br
s),5.35(0.67H,q,J=7Hz),5.37(0.33H,q,J= 7Hz),7.10-
7.19(2H,m),7.22-7.31(1H,m),7.36-7.44(1H,m)
Reference Example 3 Z (0) -1-t-butyldimethylsilyloxy-1-
(2-dipropylaminocarbonyl) phenylthio-1
-Propene and its E (O) -isomer Z (O)-and E (O)-isomer ratio 2 NMR spectrum δppm 0.10 (2H, s), 0.11 (4H, s), 0.73 (3H, t, J = 7Hz), 0.81 (3H, s),
0.89 (6H, s), 1.00 (3H, t, J = 7Hz), 1.43-1.60 (2H, m), 1.62-
1.80 (2H, m), 1.70 (2H, d, J = 7Hz), 1.77 (1H, d, J = 7Hz), 3.05
(1.3H, t, J = 7Hz), 3.08 (0.7H, t, J = 7Hz), 3.46-3.60 (2H, br
s), 5.35 (0.67H, q, J = 7Hz), 5.37 (0.33H, q, J = 7Hz), 7.10-
7.19 (2H, m), 7.22-7.31 (1H, m), 7.36-7.44 (1H, m)

【0093】[0093]

【参考例4】Z(0)−1−t−ブチルジメチルシリルオキシ−1−
(2−ジイソブチルアミノカルボニル)フェニルチオ−
1−プロペン及びそのE(O)−異性体 Z(O)- 及びE(O)- 異性体比 7 NMR スペクトル δppm 0.11(6H,s),0.75(5.3H,d,J=7Hz),0.77(0.7H,d,J=7Hz),
0.82(1.1H, s),0.90(7.9H,s),1.03(6H,d,J=7Hz),1.71
(2.6H,d,J=7Hz), 1.76(0.4H,d,J=7Hz),1.80-1.95(1H,
m),2.07-2.25(1H,m), 2.99(1.75H,d,J=8Hz),3.02(0.25
H,d,J=8Hz),3.10-3.70(2H,brs), 5.36(0.88H,q,J=7Hz),
5.42(0.12H,q,J=7Hz),7.09-7.22(2H,m), 7.23-7.30(1H,
m),7.34-7.42(1H,m)
Reference Example 4 Z (0) -1-t-butyldimethylsilyloxy-1-
(2-diisobutylaminocarbonyl) phenylthio-
1-Propene and its E (O) -isomer Z (O)-and E (O)-isomer ratio 7 NMR spectrum δppm 0.11 (6H, s), 0.75 (5.3H, d, J = 7Hz), 0.77 (0.7H, d, J = 7Hz),
0.82 (1.1H, s), 0.90 (7.9H, s), 1.03 (6H, d, J = 7Hz), 1.71
(2.6H, d, J = 7Hz), 1.76 (0.4H, d, J = 7Hz), 1.80-1.95 (1H,
m), 2.07-2.25 (1H, m), 2.99 (1.75H, d, J = 8Hz), 3.02 (0.25
H, d, J = 8Hz), 3.10-3.70 (2H, brs), 5.36 (0.88H, q, J = 7Hz),
5.42 (0.12H, q, J = 7Hz), 7.09-7.22 (2H, m), 7.23-7.30 (1H,
m), 7.34-7.42 (1H, m)

【0094】[0094]

【参考例5】Z(0)−1−t−ブチルジメチルシリルオキシ−1−
(2−N、N−メチルフェニルアミノカルボニル)フェ
ニルチオ−1−プロペン及びそのE(O)−異性体 Z(O)- 及びE(O)- 異性体比 9 NMR スペクトル δppm 0.10(0.6H,s),0.15(5.4H,
s),0.84(0.9H,s),0.92(8.1
H,s), 1.69(2.7H,d,J=7Hz),
1.79(0.3H,d,J=7Hz),3.35−
3.55(3H,brs), 5.34(0.9H,
q,J=7Hz),5.39(0.1H,q,J=7H
z),6.85−7.27(8H,broad),
7.31−7.38(1H,broad)
Reference Example 5 Z (0) -1-t-butyldimethylsilyloxy-1-
(2-N, N-methylphenylaminocarbonyl) phen
Nylthio-1-propene and its E (O) -isomer Z (O)-and E (O)-isomer ratio 9 NMR spectrum δppm 0.10 (0.6H, s), 0.15 (5.4H) ,
s), 0.84 (0.9H, s), 0.92 (8.1)
H, s), 1.69 (2.7H, d, J = 7Hz),
1.79 (0.3H, d, J = 7Hz), 3.35-
3.55 (3H, brs), 5.34 (0.9H,
q, J = 7 Hz), 5.39 (0.1H, q, J = 7H)
z), 6.85-7.27 (8H, broad),
7.31-7.38 (1H, broad)

【0095】[0095]

【参考例6】Z(0)−1−t−ブチルジメチルシリルオキシ−1−
(2−ピロリジノカルボニル)フェニルチオ−1−プロ
ペン及びそのE(O)−異性体 Z(O)− 及びE(O)- 異性体比 5 NMR スペクトル δppm 0.10(6H,s),0.79(1.5H,s),0.88(7.5H,s),1.69(2.5H,d,J
=7Hz), 1.79(0.5H,d,J=7Hz),1.80-2.02(4H,m),3.25(2H,
t,J=7Hz), 3.65(2H,t,J=7Hz),5.33(0.17H,q,J=7Hz),5.3
6(0.83H,q,J=7Hz),7.12-7.33(3H,m),7.39-7.47(1H,m)
Reference Example 6 Z (0) -1-t-butyldimethylsilyloxy-1-
(2-Pyrrolidinocarbonyl) phenylthio-1-pro
Pen and its E (O) -isomer Z (O)-and E (O) -isomer ratio 5 NMR spectrum δppm 0.10 (6H, s), 0.79 (1.5H, s), 0.88 (7.5H, s) , 1.69 (2.5H, d, J
= 7Hz), 1.79 (0.5H, d, J = 7Hz), 1.80-2.02 (4H, m), 3.25 (2H,
t, J = 7Hz), 3.65 (2H, t, J = 7Hz), 5.33 (0.17H, q, J = 7Hz), 5.3
6 (0.83H, q, J = 7Hz), 7.12-7.33 (3H, m), 7.39-7.47 (1H, m)

【0096】[0096]

【参考例7】Z(0)−1−t−ブチルジメチルシリルオキシ−1−
(2−ピペリジノカルボニル)フェニルチオ−1−プロ
ペン及びそのE(O)−異性体 Z(O)- 及びE(O)- 異性体比 3 NMR スペクトル δppm 0.10(1.5H,s),0.11(4.5H,s),0.80(2.3H,s),0.89(6.7H,
s),1.40-1.73(6H,broad),1.69(2.25H,d,J=7Hz),1.77(0.
75H,d,J=7Hz),3.15-3.28(2H,broad),3.55-3.95(2H,broa
d),5.34(0.25H,q,J=7Hz),5.34(0.75H,q,J=7Hz),7.10-7.
19(2H,m),7.22-7.32(1H,m), 7.38-7.46
(1H,m)
Reference Example 7 Z (0) -1-t-butyldimethylsilyloxy-1-
(2-piperidinocarbonyl) phenylthio-1-pro
Pen and its E (O) -isomer Z (O)-and E (O)-isomer ratio 3 NMR spectrum δppm 0.10 (1.5H, s), 0.11 (4.5H, s), 0.80 (2.3H, s) ), 0.89 (6.7H,
s), 1.40-1.73 (6H, broad), 1.69 (2.25H, d, J = 7Hz), 1.77 (0.
75H, d, J = 7Hz), 3.15-3.28 (2H, broad), 3.55-3.95 (2H, broa
d), 5.34 (0.25H, q, J = 7Hz), 5.34 (0.75H, q, J = 7Hz), 7.10-7.
19 (2H, m), 7.22-7.32 (1H, m), 7.38-7.46
(1H, m)

【0097】[0097]

【参考例8】Z(0)−1−t−ブチルジメチルシリルオキシ−1−
(2−モルホリノカルボニル)フェニルチオ−1−プロ
ペン及びそのE(O)−異性体 Z(O)- 及びE(O)- 異性体比 5 NMR スペクトル δppm 0.10(1H,s),0.11(5H,s),0.7
9(1.5H,s),0.89(7.5H,s),1.
70(2.5H,d,J=7Hz),1.78(0.5
H,d,J=7Hz),3.18−3.40(2H,b
road),3.52−3.85(2H,brs),
3.65−3.90(4H,brs),5.34(0.
17H,q,J=7Hz),5.35(0.83H,
q,J=7Hz),7.13−7.21(2H,m),
7.25−7.36(1H,m),7.40−7.47
(1H,m)
Reference Example 8 Z (0) -1-t-butyldimethylsilyloxy-1-
(2-morpholinocarbonyl) phenylthio-1-pro
Pen and its E (O) -isomer Z (O)-and E (O)-isomer ratio 5 NMR spectrum δppm 0.10 (1H, s), 0.11 (5H, s), 0.7
9 (1.5H, s), 0.89 (7.5H, s), 1.
70 (2.5H, d, J = 7Hz), 1.78 (0.5
H, d, J = 7 Hz), 3.18-3.40 (2H, b
road), 3.52-3.85 (2H, brs),
3.65-3.90 (4H, brs), 5.34 (0.
17H, q, J = 7Hz), 5.35 (0.83H,
q, J = 7 Hz), 7.13-7.21 (2H, m),
7.25-7.36 (1H, m), 7.40-7.47
(1H, m)

【0098】[0098]

【参考例9】Z(0)−1−t−ブチルジメチルシリルオキシ−1−
(2−(2H−1、3、4、5、6、7−ヘキサヒドロ
アゼピノ)カルボニル)フェニルチオ−1−プロペン及
びそのE(O)−異性体 Z(O)− 及びE(O)- 異性体比 3 NMR スペクトル δppm 0.10(1.5H,s),0.12(4.5H,s),0.79(2.3H,s),0.90(6.7H,
s),1.53-1.72(6H,broad),1.69(2.25H,d,J=7Hz),1.78(0.
75H,d,J=7Hz),1.75-1.90(2H,broad),3.19-3.35(2H,broa
d),3.55-3.80(2H,broad),5.33(0.25H,q,J=7Hz),5.34(0.
75H,q,J=7Hz),7.10-7.19(2H,m),7.21-7.33(1H,m),7.38-
7.46(1H,m)
Reference Example 9 Z (0) -1-t-butyldimethylsilyloxy-1-
(2- (2H-1,3,4,5,6,7-hexahydro
Azepino) carbonyl) phenylthio-1-propene and
And its E (O) -isomer Z (O)-and E (O)-isomer ratio 3 NMR spectrum δppm 0.10 (1.5H, s), 0.12 (4.5H, s), 0.79 (2.3H, s), 0.90 (6.7H,
s), 1.53-1.72 (6H, broad), 1.69 (2.25H, d, J = 7Hz), 1.78 (0.
75H, d, J = 7Hz), 1.75-1.90 (2H, broad), 3.19-3.35 (2H, broa
d), 3.55-3.80 (2H, broad), 5.33 (0.25H, q, J = 7Hz), 5.34 (0.
75H, q, J = 7Hz), 7.10-7.19 (2H, m), 7.21-7.33 (1H, m), 7.38-
7.46 (1H, m)

【0099】[0099]

【参考例10】Z(0)−1−t−ブチルジメチルシリルオキシ−1−
(2−ジエチルアミノカルボニル−6−メチル)フェニ
ルチオ−1−プロペン及びそのE(O)−異性体 Z(O)- 及びE(O)- 異性体比 11 NMR スペクトル δppm 0.21(3H,s),0.23(3H,s),0.96(9H,s),1.03(3H,t,J=7Hz),
1.27(3H,t,J=7Hz),1.49(3H,d,J=7Hz),2.51(3H,s),3.08
(1H,dq,J=14and7Hz),3.11(1H,dq,J=14and7Hz),3.43(1H,
dq,J=14and7Hz),3.70(1H,dq,J=14and7Hz),4.12(1H,q,J=
7Hz),7.08-7.13(1H,m),7.25-7.32(2H,m)
Reference Example 10 Z (0) -1-t-butyldimethylsilyloxy-1-
(2-Diethylaminocarbonyl-6-methyl) phenyl
Ruthio-1-propene and its E (O) -isomer Z (O)-and E (O)-isomer ratio 11 NMR spectrum δppm 0.21 (3H, s), 0.23 (3H, s), 0.96 (9H, s), 1.03 (3H, t, J = 7Hz),
1.27 (3H, t, J = 7Hz), 1.49 (3H, d, J = 7Hz), 2.51 (3H, s), 3.08
(1H, dq, J = 14and7Hz), 3.11 (1H, dq, J = 14and7Hz), 3.43 (1H,
dq, J = 14and7Hz), 3.70 (1H, dq, J = 14and7Hz), 4.12 (1H, q, J =
7Hz), 7.08-7.13 (1H, m), 7.25-7.32 (2H, m)

【0100】[0100]

【参考例11】Z(0)−1−t−ブチルジメチルシリルオキシ−1−
(2−ジエチルアミノチオカルボニル)フェニルチオ−
1−プロペン及びそのE(O)−異性体 Z(O)- 及びE(O)- 異性体比 20 NMR スペクトル δppm 0.12(3H,s),0.14(3H,s),0.80(9/21H,s),0.91(180/21H,
s),1.11(3H,t,J=7Hz),1.40(3H,t,J=7Hz),1.70(60/21H,
d,J=7Hz),1.78(3/21H,d,J=7Hz),3.29(1H,dq,J=7and14H
z),3.44(1H,dq,J=7and14Hz),3.67(1H,dq,J=7and14Hz),
4.57(1H,dq,J=7and14Hz),5.38(1H,q,J=7Hz),7.10-7.25
(3H,m),7.31-7.40(1H,m)
Reference Example 11 Z (0) -1-t-butyldimethylsilyloxy-1-
(2-Diethylaminothiocarbonyl) phenylthio-
1-Propene and its E (O) -isomer Z (O)-and E (O)-isomer ratio 20 NMR spectrum δppm 0.12 (3H, s), 0.14 (3H, s), 0.80 (9 / 21H, s), 0.91 (180 / 21H,
s), 1.11 (3H, t, J = 7Hz), 1.40 (3H, t, J = 7Hz), 1.70 (60 / 21H,
d, J = 7Hz), 1.78 (3 / 21H, d, J = 7Hz), 3.29 (1H, dq, J = 7and14H
z), 3.44 (1H, dq, J = 7and14Hz), 3.67 (1H, dq, J = 7and14Hz),
4.57 (1H, dq, J = 7and14Hz), 5.38 (1H, q, J = 7Hz), 7.10-7.25
(3H, m), 7.31-7.40 (1H, m)

【0101】[0101]

【参考例12】チオプロピオン酸S−(2−ジエチルアミノカルボニ
ル)フェニルエステル A法 氷冷した2,2’−ジチオベンゾイルクロリド71.62g
(0.209mol)の塩化メチレン300ml懸濁液に、ジエチル
アミン34.84g(0.476mol)とトリエチルアミン70.0ml(0.5
02mol)の塩化メチレン50ml溶液を1時間かけて滴下
し、同温度でさらに30分間撹拌した。塩化メチレンを
減圧下留去して得られる残渣を酢酸エチルで希釈し水、
飽和食塩水で順次洗浄した。再び溶剤を留去し、アミド
化合物を得た。このようにして得られたアミド化合物の
うちの約4gと亜鉛末14.36 g(0.220mol)、無水プロピ
オン酸80.0ml(0.624mol)の混合物を100℃で5分間加
熱し、反応を行うと供に亜鉛の活性化を行った。ついで
同温度で残りのアミド化合物のベンゼン100ml溶液を
20分かけて滴下し、さらに90分間加熱還流した。冷
後析出した結晶を濾去し、結晶を酢酸エチルで洗浄し
た。濾液と洗液を合せ、水洗した後、溶剤を留去した、
残渣を減圧蒸留し標記化合物106.97g(2工程,96
%)を得た。bp167〜170℃/0.95〜1.1mmHg IRスペクトル(liq)cm-1 :1710,1635,1292,932 NMR スペクトル(270MHz,CDCl3)δppm :1.02(3H,t,J=7H
z),1.20(3H,t,J=7Hz),1.23(3H,t,J=7Hz),2.66(2H,q,J=7
Hz),2.90-3.20(2H,broad),3.10-4.00(2H,broad),7.29-
7.36(1H,m),7.40-7.52(1H,m) マススペクトル(m/z) ,266(M++1), 265(M+,C14H
19NO2S) B法 a.チオサリチル酸3.13g(20.3mmol)とトリエチルアミ
ン2.46g(24.4mmol)の塩化メチレン60ml溶液を氷冷
し、塩化ベンゾイル2.85g(20.3mmol)を滴下した。滴下
後さらに室温で1時間撹拌し、反応液を0.2 N塩酸で2
回、飽和食塩水で1回洗浄した。溶剤を留去し5.24g
(定量的収率)のベンゾイルチオ安息香酸の粗結晶を得
た。これを塩化メチレン100mlに溶かし、氷冷下、ヨ
ウ化2−クロロ−1−メチルピリジニウム5.45g(21.3m
mol)、ジエチルアミン1.78g(24.4mmol)及びトリエチル
アミン4.51g(44.7mmol)を順次加えた後、室温で20時
間撹拌した。溶剤を留去して得られた残渣を酢酸エチル
と希塩酸に分配し、さらに有機層を水洗した。溶剤を留
去し残渣をシリカゲル120gを用いるカラムクロマト
グラフィーに付しヘキサン−アセトン(4〜3:1)で
溶出して4.86g(76%)のN,N−ジエチル2−ベン
ゾイルチオベンズアミドを油状物質として得た。NMR ス
ペクトル(60MHz,CDCl3) δppm :0.99(3H,t,J=7Hz),1.0
2(3H,t,J=7Hz),3.09(2H,q,J=7Hz),3.0-3.9(2H,broad),
7.2-7.7(7.5H,m),7.9-8.2(1.5H,m) b.aで得られた化合物4.86g(15.5mmol)のメタノール
60ml溶液を氷冷し、ナトリウムメトキシド0.84g(15.
5mmol)を加えて20分間撹拌した。濃塩酸約15滴を加
えて反応液を中和した後、さらにエタノールを加えて溶
剤を留去した。水分を除くためにエタノール20mlとベ
ンゼン30mlを加えて再び溶剤を留去した。このように
して得られたN,N−ジエチル−2メルカプトベンズア
ミドを含む残渣を塩化メチレン60mlに懸濁し、氷冷下
塩化プロピオニル4.30g(46.5mmol)とトリエチルアミン
6.26g(62.0mmol)を加えて2.5 時間撹拌した。水を加え
て反応を終結させ塩化メチレンで希釈した。有機層を希
塩酸、水で洗浄した後、溶剤を留去し、残渣をシリカゲ
ル100gを用いるカラムクロマトグラフィーで精製し
3.26g(79%)の標記化合物を得た。本化合物はA法
によって得られたものと同一であった。参考例12のA
法またはB法によって参考例13〜21の化合物を製造
した。
[Reference Example 12] Thiopropionic acid S- (2-diethylamino carbonate
) Phenyl ester A method 71.62 g of ice-cooled 2,2'-dithiobenzoyl chloride
In a 300 ml suspension of methylene chloride (0.209 mol), 34.84 g (0.476 mol) of diethylamine and 70.0 ml (0.5
A solution of 02 mol) in 50 ml of methylene chloride was added dropwise over 1 hour, and the mixture was stirred at the same temperature for 30 minutes. The residue obtained by distilling methylene chloride under reduced pressure was diluted with ethyl acetate and water,
It was washed successively with saturated saline. The solvent was distilled off again to obtain an amide compound. A mixture of about 4 g of the amide compound thus obtained, zinc powder 14.36 g (0.220 mol), and propionic anhydride 80.0 ml (0.624 mol) was heated at 100 ° C. for 5 minutes to carry out the reaction. Activation of zinc was performed. Then, a solution of the remaining amide compound in 100 ml of benzene was added dropwise at the same temperature over 20 minutes, and the mixture was heated under reflux for 90 minutes. The crystals precipitated after cooling were filtered off, and the crystals were washed with ethyl acetate. The filtrate and washing liquid were combined, washed with water, and then the solvent was distilled off,
The residue was distilled under reduced pressure and 106.97 g of the title compound (2 steps, 96
%) Was obtained. bp 167 to 170 ° C./0.95 to 1.1 mmHg IR spectrum (liq) cm −1 : 1710,1635,1292,932 NMR spectrum (270 MHz, CDCl 3 ) δppm: 1.02 (3H, t, J = 7H
z), 1.20 (3H, t, J = 7Hz), 1.23 (3H, t, J = 7Hz), 2.66 (2H, q, J = 7
Hz), 2.90-3.20 (2H, broad), 3.10-4.00 (2H, broad), 7.29-
7.36 (1H, m), 7.40-7.52 (1H, m) Mass spectrum (m / z), 266 (M + +1), 265 (M + , C 14 H
19 NO 2 S) Method B a. A solution of 3.13 g (20.3 mmol) of thiosalicylic acid and 2.46 g (24.4 mmol) of triethylamine in 60 ml of methylene chloride was ice-cooled, and 2.85 g (20.3 mmol) of benzoyl chloride was added dropwise. After dropping, the mixture was stirred at room temperature for 1 hour, and the reaction solution was diluted with 0.2 N hydrochloric acid to 2
It was washed once with saturated saline. 5.24g after distilling off the solvent
Crude crystals of benzoylthiobenzoic acid were obtained (quantitative yield). This was dissolved in 100 ml of methylene chloride, and under ice-cooling, 2.45 g (21.3 m) of 2-chloro-1-methylpyridinium iodide.
mol), diethylamine 1.78 g (24.4 mmol) and triethylamine 4.51 g (44.7 mmol) were sequentially added, and the mixture was stirred at room temperature for 20 hours. The solvent was evaporated and the obtained residue was partitioned between ethyl acetate and dilute hydrochloric acid, and the organic layer was washed with water. The solvent was distilled off, and the residue was subjected to column chromatography using 120 g of silica gel and eluted with hexane-acetone (4-3: 1) to obtain 4.86 g (76%) of N, N-diethyl 2-benzoylthiobenzamide as an oil. Obtained as a substance. NMR spectrum (60MHz, CDCl 3 ) δppm: 0.99 (3H, t, J = 7Hz), 1.0
2 (3H, t, J = 7Hz), 3.09 (2H, q, J = 7Hz), 3.0-3.9 (2H, broad),
7.2-7.7 (7.5H, m), 7.9-8.2 (1.5H, m) b. A solution of 4.86 g (15.5 mmol) of the compound obtained in a in 60 ml of methanol was ice-cooled and 0.84 g of sodium methoxide (15.
(5 mmol) was added and stirred for 20 minutes. After about 15 drops of concentrated hydrochloric acid was added to neutralize the reaction solution, ethanol was further added to distill off the solvent. To remove water, 20 ml of ethanol and 30 ml of benzene were added and the solvent was distilled off again. The residue containing N, N-diethyl-2mercaptobenzamide thus obtained was suspended in 60 ml of methylene chloride, and under cooling with ice, 4.30 g (46.5 mmol) of propionyl chloride and triethylamine were added.
6.26 g (62.0 mmol) was added and stirred for 2.5 hours. The reaction was terminated by adding water and diluted with methylene chloride. The organic layer was washed with dilute hydrochloric acid and water, the solvent was distilled off, and the residue was purified by column chromatography using 100 g of silica gel.
Obtained 3.26 g (79%) of the title compound. This compound was the same as that obtained by Method A. A of Reference Example 12
The compounds of Reference Examples 13 to 21 were produced by the method B or method B.

【0102】[0102]

【参考例13】チオプロピオン酸S−(2−ジメチルアミノカルボニ
ル)フェニルエステル 収率(2工程、%) 78 IRスペクトル カルボニル吸収(cm-1) 1709,
1639
[Reference Example 13] Thiopropionic acid S- (2-dimethylamino carbonate
) Phenyl ester yield (2 steps,%) 78 IR spectrum Carbonyl absorption (cm −1 ) 1709,
1639

【0103】[0103]

【参考例14】チオプロピオン酸S−(2−ジプロピルアミノカルボニ
ル)フェニルエステル 収率(2工程、%) 93 IRスペクトル カルボニル吸収(cm-1) 1705,
1632
[Reference Example 14] Thiopropionic acid S- (2-dipropylaminocarbonyl)
) Phenyl ester yield (2 steps,%) 93 IR spectrum Carbonyl absorption (cm −1 ) 1705
1632

【0104】[0104]

【参考例15】チオプロピオン酸S−(2−ジイソブチルアミノカルボ
ニル)フェニルエステル 収率(2工程、%) 99 IRスペクトルカルボニル吸収(cm-1) 1712,
1635
Reference Example 15 S- (2-diisobutylaminocarbothiothiopropionate
Nyl) phenyl ester yield (2 steps,%) 99 IR spectrum Carbonyl absorption (cm −1 ) 1712,
1635

【0105】[0105]

【参考例16】チオプロピオン酸S−(2−N、N−メチルフェニルア
ミノカルボニル)フェニルエステル 収率(2工程、%) 96 IRスペクトル カルボニル吸収(cm-1) 1705,
1645
Reference Example 16 S- (2-N, N-methylphenylthiothiopropionate
Minocarbonyl) phenyl ester yield (2 steps,%) 96 IR spectrum Carbonyl absorption (cm -1 ) 1705
1645

【0106】[0106]

【参考例17】チオプロピオン酸S−(2−ピロリジノカルボニル)フ
ェニルエステル 収率(2工程、%) 74 IRスペクトル カルボニル吸収(cm-1) 1702,
1630
Reference Example 17 S- (2-pyrrolidinocarbonyl ) thiopropionate
Yield of ester (2 steps,%) 74 IR spectrum Carbonyl absorption (cm −1 ) 1702
1630

【0107】[0107]

【参考例18】チオプロピオン酸S−(2−ピペリジノカルボニル)フ
ェニルエステル 収率(2工程、%) 98 IRスペクトル カルボニル吸収(cm-1) 1702,
1630
[Reference Example 18] S- (2-piperidinocarbonyl ) thiopropionate
Yenyl ester yield (2 steps,%) 98 IR spectrum Carbonyl absorption (cm −1 ) 1702
1630

【0108】[0108]

【参考例19】チオプロピオン酸S−(2−モルホリノカルボニル)フ
ェニルエステル 収率(2工程、%) 89 IRスペクトル カルボニル吸収(cm-1) 1702,
1635
Reference Example 19 S- (2-morpholinocarbonyl) thiopropionate
Yenyl ester yield (2 steps,%) 89 IR spectrum Carbonyl absorption (cm −1 ) 1702
1635

【0109】[0109]

【参考例20】チオプロピオン酸S−(2−(2H−1、3、4、5、
6、7−ヘキサヒドロアゼピノ)カルボニル)フェニル
エステル 収率(2工程、%) 93 IRスペクトル カルボニル吸収(cm-1) 1705,
1630
[Reference Example 20] Thiopropionic acid S- (2- (2H-1, 3, 4, 5,
6,7-Hexahydroazepino) carbonyl) phenyl
Ester yield (2 steps,%) 93 IR spectrum Carbonyl absorption (cm −1 ) 1705
1630

【0110】[0110]

【参考例21】チオプロピオン酸S−(2−ジエチルアミノカルボニル
−6−メチル)フェニルエステル 収率(2工程、%) 38 IRスペクトル カルボニル吸収(cm-1) 1703,
1635
[Reference Example 21] Thiopropionic acid S- (2-diethylaminocarbonyl)
-6-Methyl) phenyl ester yield (2 steps,%) 38 IR spectrum Carbonyl absorption (cm -1 ) 1703.
1635

【0111】[0111]

【参考例22】チオプロピオン酸S−(2−ジエチルアミノチオカルボ
ニル)フェニルエステル 参考例12の化合物276mg(1.04mmol)をトルエン(5m
l) に溶解し、そこへローソン試薬216mg(0.534mmol)
を加え、100℃で2時間攪拌しながら加熱した。反
応終了後、冷却しそのままシリカゲル25g を用いてク
ロマト(塩化メチレン:ヘキサン=3:0〜3:1で溶
出)を行い、S−2−ジエチルアミノチオカルボニルフ
ェニルチオプロピオネート286mgを得た。 融点:6
7.5-68.5 ℃ IRスペクトル(nuj)cm-1 :1712,1505,1308,1242,928 NMR スペクトル(270MHz,CDCl3)δppm :1.08(3H,t,J=7H
z),1.20(3H,t,J=7Hz),1.37(3H,t,J=7Hz),2.66(2H,q,J=7
Hz),3.19(1H,dq,J=14and7Hz),3.38(1H,dq,J=14and7Hz),
3.70(1H,dq,J=14and7Hz),4.53(1H,dq,J=14and7Hz),3.29
(1H,dq,J=7and14Hz),3.67(1H,dq,J=7and14Hz),4.57(1H,
dq,J=7and14Hz),5.37(1H,q,J=7Hz),7.10-7.25(3H,m),7.
31-7.47(3H,m) マススペクトル(m/z) :281(M+,C14H19NOS2) 収率(2工程、%) 38 IRスペクトルカルボニル吸収(cm-1)1703,163
Reference Example 22 S- (2-diethylaminothiocarbothiothiopropionate
Nyl ) phenyl ester 276 mg (1.04 mmol) of the compound of Reference Example 12 was added to toluene (5 m
l), and Lawson's reagent 216 mg (0.534 mmol)
Was added and heated at 100 ° C. for 2 hours with stirring. After the completion of the reaction, the reaction mixture was cooled and chromatographed (eluted with methylene chloride: hexane = 3: 0-3: 1) using 25 g of silica gel as it was to obtain 286 mg of S-2-diethylaminothiocarbonylphenylthiopropionate. Melting point: 6
7.5-68.5 ℃ IR spectrum (nuj) cm -1 : 1712,1505,1308,1242,928 NMR spectrum (270MHz, CDCl 3 ) δppm: 1.08 (3H, t, J = 7H
z), 1.20 (3H, t, J = 7Hz), 1.37 (3H, t, J = 7Hz), 2.66 (2H, q, J = 7
Hz), 3.19 (1H, dq, J = 14and7Hz), 3.38 (1H, dq, J = 14and7Hz),
3.70 (1H, dq, J = 14and7Hz), 4.53 (1H, dq, J = 14and7Hz), 3.29
(1H, dq, J = 7and14Hz), 3.67 (1H, dq, J = 7and14Hz), 4.57 (1H,
dq, J = 7and14Hz), 5.37 (1H, q, J = 7Hz), 7.10-7.25 (3H, m), 7.
31-7.47 (3H, m) mass spectrum (m / z): 281 ( M +, C 14 H 19 NOS 2) yield (2 steps,%) 38 IR spectrum carbonyl absorption (cm -1) 1703,163
5

【0112】[0112]

【参考例23】プロピオン酸 (2−ジエチルアミノカルボニル)フェ
ニルエステル 2−プロピオニルオキシ安息香酸2.40g(12.4mmol)
を塩化メチレン24mlに溶解し、そこへ氷冷下、オキザ
リルクロリド2.0ml(23mmol)及びジメチルホルムアミ
ド0.050mlを加えて、1時間攪拌した。減圧下、溶
媒及び過剰のオキザリルクロリドを留去した。残渣に、
塩化メチレン20mlを加え、さらに氷冷下、トリエチル
アミン1.36g(13.5mmol) 及びジエチルアミン986
mg(13.5mmol)を加えて、1時間攪拌した。反応終了後、
酢酸エチルを加え、水洗した。溶媒を留去し、残渣をシ
リカゲル25g クロマト(塩化メチレン:酢酸エチル=
10:1〜7:1)を行い、2−ジエチルアミノカルボ
ニルフェニルプロピオネート3.0g (収率97%)を油
状物として得た。 IRスペクトル(liq)cm-1 :1765,1638,1430,1293,1142 NMR スペクトル(60MHz,CDCl3) δppm :1.06(3H,t,J=7H
z),1.20(6H,t,J=7Hz),2.52(2H,q,J=7Hz),3.15(2H,q,J=7
Hz),3.49(2H,q,J=7Hz),7.0-7.6(4H,m) マススペクトル(m/z) :249(M+,C14H19NO3)
[Reference Example 23] Propionic acid (2-diethylaminocarbonyl) phene
Nyl ester 2-propionyloxybenzoic acid 2.40 g (12.4 mmol)
Was dissolved in 24 ml of methylene chloride, 2.0 ml (23 mmol) of oxalyl chloride and 0.050 ml of dimethylformamide were added thereto under ice cooling, and the mixture was stirred for 1 hour. The solvent and excess oxalyl chloride were distilled off under reduced pressure. In the residue,
20 ml of methylene chloride was added, and under ice cooling, 1.36 g (13.5 mmol) of triethylamine and 986 of diethylamine were added.
mg (13.5 mmol) was added and stirred for 1 hour. After the reaction,
Ethyl acetate was added and washed with water. The solvent was distilled off, and the residue was chromatographed on 25 g of silica gel (methylene chloride: ethyl acetate =
10: 1 to 7: 1) was carried out to obtain 3.0 g of 2-diethylaminocarbonylphenylpropionate (yield 97%) as an oily substance. IR spectrum (liq) cm -1: 1765,1638,1430,1293,1142 NMR spectrum (60MHz, CDCl 3) δppm: 1.06 (3H, t, J = 7H
z), 1.20 (6H, t, J = 7Hz), 2.52 (2H, q, J = 7Hz), 3.15 (2H, q, J = 7
Hz), 3.49 (2H, q, J = 7Hz), 7.0-7.6 (4H, m) Mass spectrum (m / z): 249 (M + , C 14 H 19 NO 3 )

【0113】[0113]

【参考例24】(3S,4S)−3−[(1R)−1−t−ブチルジメ
チルシリルオキシエチル]−4−[(1R)−[(2
S,4S)−2−[4−(2−p−ニトロベンジルオキ
シエチル)ピペラジン−1−イルカルボニル]−1−p
ニトロベンジルオキシカルボニルピロリジル−4−イ
ル]チオカルボニルエチル]アゼチジン−2−オン 実施例1で得られた化合物99mg(0.20mmol)、(2S,
4S)−2−{4−[2−(p−ニトロベンジルオキシ
カルボニル)オキシエチル]−1−ピペラジニルカルボ
ニル}−4−メルカプト−1−(p−ニトロベンジルオ
キシカルボニル)ピロリジン135mg(0.22mmol)、及び
トリエチルアミン30mg(0.30mmol)の塩化メチレン2ml
溶液を室温で17時間撹拌した。溶剤を留去して得られ
る残渣を酢酸エチルに溶かし2N苛性ソーダ、水、飽和
食塩水で順次洗浄した。溶剤を留去した後、残渣をシリ
カゲル25gを用いるカラムクロマトグラフィーに付
し、アセトン−ヘキサン(3:2)で溶出し、泡状の標
記化合物182mg(定量的収率)を得た。
Reference Example 24 (3S, 4S) -3-[(1R) -1-t-butyldime
Cylsilyloxyethyl] -4-[(1R)-[(2
S, 4S) -2- [4- (2-p-nitrobenzyloxy
Ciethyl) piperazin-1-ylcarbonyl] -1-p
Nitrobenzyloxycarbonylpyrrolidyl-4-i
]] Thiocarbonylethyl] azetidin-2-one 99 mg (0.20 mmol) of the compound obtained in Example 1, (2S,
4S) -2- {4- [2- (p-nitrobenzyloxycarbonyl) oxyethyl] -1-piperazinylcarbonyl} -4-mercapto-1- (p-nitrobenzyloxycarbonyl) pyrrolidine 135 mg (0.22 mmol) , And triethylamine 30 mg (0.30 mmol) methylene chloride 2 ml
The solution was stirred at room temperature for 17 hours. The residue obtained by distilling off the solvent was dissolved in ethyl acetate and washed successively with 2N caustic soda, water and saturated saline. After evaporating the solvent, the residue was subjected to column chromatography using 25 g of silica gel and eluted with acetone-hexane (3: 2) to obtain 182 mg (quantitative yield) of the title compound as a foam.

【0114】[0114]

【参考例25】(3S,4S)−3−[(R)−1−ヒドロキシエチ
ル]−4−[[(R)−1−[(2S,4S)−2−4
−2−(4−ニトロベンジルオキシカルボニルオキシ)
エチル−1−ピペラジニルカルボニル−1−(4−ニト
ロベンジルオキシカルボニル)ピロリジン−4−イルチ
オカルボニルエチル]アゼチジン−2−オン (3S,4S)−3−[(R)−1−(t−ブチルジメ
チルシリルオキシ)エチル]−4−[(R)−1−
[(2S,4S)−2−[4−[2−(4−ニトロベン
ジルオキシカルボニルオキシ)エチル]−1−ピペラジ
ニルカルボニル]−1−(4−ニトロベンジルオキシカ
ルボニル)ピロリジン−4−イル−チオカルボニル]エ
チル]−2−アゼチジノン(8.1g) をメタノール(80
ml)に溶解し、氷冷下、撹拌しながら3N塩酸(24m
l)を滴下した。滴下後同温度で30分撹拌し、さらに
冷蔵庫に1晩放置した後、反応混合物を氷冷し、炭酸水
素ナトリウムでpHを5〜6に調整した。ついで減圧下濃
縮し、残渣に少量の水を加えて酢酸エチルで抽出した。
更に水層を食塩で飽和し、同溶媒で抽出した。抽出液を
あわせ、溶媒を減圧下留去した。残渣をシリカゲル15
0gを用いるカラムクロマトグラフィーに付し、酢酸エ
チル:メタノール=20〜10:1の混合溶媒で溶出す
ると無色泡状化合物の目的化合物(5.9g) が得られた。 IRスペクトル(CHCl3)cm-1 :1752,1710,1650,1607,152
2,1443,1405,1347,1263 NMR スペクトル(270MHz,CDCl3):1.27(3H,d,J=6.83Hz),
1.28(3H,d,J=6.35Hz),1.82-1.99(1H,m),2.10-2.18(1H,
m),2.40-2.95(7H,m),3.03(1H,dd,J=1.95,6.35Hz),3.37-
3.80(5H,m),3.78(1H,dd,J=1.95,6.84Hz),3.95-4.48(6H,
m),4.68,4.73(1H,t×2,J=8.06,7.33Hz),5.06,5.32(1H,d
×2,J=13.43Hz),5.21(1H,s),5.26(2H,s)5.99(1H,br.
s),7.45,7.50(2H,d×2,J=8.30,8.79Hz),7.56(2H,d,J=8.
79Hz),8.18-8.26(4H,m)
Reference Example 25 (3S, 4S) -3-[(R) -1-hydroxyethyl
] -4-[[(R) -1-[(2S, 4S) -2-4]
-2- (4-nitrobenzyloxycarbonyloxy)
Ethyl-1-piperazinylcarbonyl-1- (4-nit
Robenzyloxycarbonyl) pyrrolidin-4-ylchi
Ocarbonylethyl] azetidin-2-one (3S, 4S) -3-[(R) -1- (t-butyldimethylsilyloxy) ethyl] -4-[(R) -1-
[(2S, 4S) -2- [4- [2- (4-Nitrobenzyloxycarbonyloxy) ethyl] -1-piperazinylcarbonyl] -1- (4-nitrobenzyloxycarbonyl) pyrrolidin-4-yl -Thiocarbonyl] ethyl] -2-azetidinone (8.1 g) was added to methanol (80
3N hydrochloric acid (24m) while stirring under ice cooling.
l) was added dropwise. After the dropwise addition, the mixture was stirred at the same temperature for 30 minutes and left in a refrigerator overnight, then the reaction mixture was ice-cooled and the pH was adjusted to 5 to 6 with sodium hydrogen carbonate. Then, the mixture was concentrated under reduced pressure, a small amount of water was added to the residue, and the mixture was extracted with ethyl acetate.
Further, the aqueous layer was saturated with sodium chloride and extracted with the same solvent. The extracts were combined and the solvent was evaporated under reduced pressure. The residue is silica gel 15
By subjecting to column chromatography using 0 g and eluting with a mixed solvent of ethyl acetate: methanol = 20 to 10: 1, the target compound (5.9 g) was obtained as a colorless foamy compound. IR spectrum (CHCl 3 ) cm −1 : 1752,1710,1650,1607,152
2,1443,1405,1347,1263 NMR spectrum (270 MHz, CDCl 3 ): 1.27 (3H, d, J = 6.83Hz),
1.28 (3H, d, J = 6.35Hz), 1.82-1.99 (1H, m), 2.10-2.18 (1H,
m), 2.40-2.95 (7H, m), 3.03 (1H, dd, J = 1.95,6.35Hz), 3.37-
3.80 (5H, m), 3.78 (1H, dd, J = 1.95,6.84Hz), 3.95-4.48 (6H,
m), 4.68,4.73 (1H, t × 2, J = 8.06,7.33Hz), 5.06,5.32 (1H, d
× 2, J = 13.43Hz), 5.21 (1H, s), 5.26 (2H, s) 5.99 (1H, br.
s), 7.45,7.50 (2H, d × 2, J = 8.30,8.79Hz), 7.56 (2H, d, J = 8.
79Hz), 8.18-8.26 (4H, m)

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】一般式 【化1】 [式中、R1 は水素原子または水酸基の保護基を示し、 R2 は炭素数1乃至6個の直鎖若しくは分枝鎖のアルキ
ル基、炭素数1乃至6個の直鎖若しくは分枝鎖のアルコ
キシ基、ハロゲン原子、無置換若しくは下記α群から選
択された置換分を有するフェニル基又は無置換若しくは
下記α群から選択された置換分を有するフェノキシ基を
示し、 R3 はCYNR56 基(式中、Yは酸素又は硫黄原子
を示し、R5 及びR6はそれぞれ独立に炭素数1乃至6
個の直鎖若しくは分枝鎖のアルキル基、無置換若しくは
下記α群から選択された置換分を有するアリ−ル基又は
無置換若しくは下記α群から選択された置換分を有する
アラルキル基を示すか、R5 とR6 が一緒になって式−
(CH2)m(X)L(CH2)n−基(式中、m及びnは同一又は異っ
て0乃至5(但し、m+nは2以上である。)を示し、
Lは0または1、Xは酸素、硫黄原子またはNR7
(R7 は炭素数1乃至6個の直鎖若しくは分枝鎖のアル
キル基、炭素数1乃至6個の直鎖若しくは分枝鎖の脂肪
族アシル基、無置換若しくは下記α群から選択された置
換分を有する芳香族アシル基を示す。)を示す。)を示
す。)を置換基として有しており、かつ、下記α群から
選択された置換分を有してもよいフェニル基を示し、 R4 は水素原子又はアミノ基の保護基を示し、 Zは酸素又は硫黄原子を示す。]を有する化合物。 [α群]ハロゲン原子、シアノ基、ニトロ基、水酸基、
アミノ基、炭素数1乃至4個のアルキルアミノ基、炭素
数1乃至4個のアルキル基を2個有するジアルキルアミ
ノ基、炭素数1乃至3個のアルキレンジオキシ基。
1. A general formula: [Wherein R 1 represents a hydrogen atom or a protective group for a hydroxyl group, R 2 represents a linear or branched alkyl group having 1 to 6 carbon atoms, a linear or branched chain having 1 to 6 carbon atoms] An alkoxy group, a halogen atom, a phenyl group having no substituent or a substituent selected from the following α group, or a phenoxy group having no substituent or a substituent selected from the following α group, R 3 is CYNR 5 R 6 A group (in the formula, Y represents an oxygen atom or a sulfur atom, R 5 and R 6 each independently have 1 to 6 carbon atoms)
A straight or branched chain alkyl group, an unsubstituted or substituted aryl group having a substituent selected from the following α group, or an unsubstituted or aralkyl group having a substituent selected from the following α group , R 5 and R 6 together form the formula −
(CH 2) m (X) L (CH 2) n - group (wherein, m and n to 0 me identical or different 5 (however, m + n indicates 2 or more).
L is 0 or 1, X is an oxygen atom, a sulfur atom or an NR 7 group (R 7 is a linear or branched alkyl group having 1 to 6 carbon atoms, a linear or branched chain having 1 to 6 carbon atoms) Of the above-mentioned aliphatic acyl group, which is unsubstituted or has a substituent selected from the following α group). ) Is shown. ) As a substituent and which may have a substituent selected from the following α group, R 4 represents a hydrogen atom or an amino-protecting group, and Z represents oxygen or Indicates a sulfur atom. ] The compound which has. [Α group] halogen atom, cyano group, nitro group, hydroxyl group,
An amino group, an alkylamino group having 1 to 4 carbon atoms, a dialkylamino group having two alkyl groups having 1 to 4 carbon atoms, and an alkylenedioxy group having 1 to 3 carbon atoms.
JP17409992A 1991-07-12 1992-07-01 1β-substituted carbapenem synthetic intermediate Expired - Fee Related JP3175857B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP17409992A JP3175857B2 (en) 1991-07-12 1992-07-01 1β-substituted carbapenem synthetic intermediate

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3-172220 1991-07-12
JP17222091 1991-07-12
JP17409992A JP3175857B2 (en) 1991-07-12 1992-07-01 1β-substituted carbapenem synthetic intermediate

Publications (2)

Publication Number Publication Date
JPH05201968A true JPH05201968A (en) 1993-08-10
JP3175857B2 JP3175857B2 (en) 2001-06-11

Family

ID=26494649

Family Applications (1)

Application Number Title Priority Date Filing Date
JP17409992A Expired - Fee Related JP3175857B2 (en) 1991-07-12 1992-07-01 1β-substituted carbapenem synthetic intermediate

Country Status (1)

Country Link
JP (1) JP3175857B2 (en)

Also Published As

Publication number Publication date
JP3175857B2 (en) 2001-06-11

Similar Documents

Publication Publication Date Title
IE48728B1 (en) Process for the preparation of thienamycin and intermediates
US4443373A (en) Process for the production of antibiotic penems
JP3787819B2 (en) Azetidinone compound and method for producing the same
US9701684B2 (en) Chiral fluorinating reagents
IE57609B1 (en) Process for the production of penems
JPH03395B2 (en)
US4427586A (en) 2-Oxoazetidine derivatives and production thereof
KR100337053B1 (en) Thiol compounds
JP3175857B2 (en) 1β-substituted carbapenem synthetic intermediate
HU196809B (en) Process for producing 7-oxo-4-thia-1-azabicyclo/3.2.0/-hept-2-ene derivatives
US4647558A (en) Antibacterial agents, their preparation and use
JPH03383B2 (en)
FI105810B (en) Use of (3S, 4S) -3 - [(1R) -1-trialkylsilyloxyethyl] -4 - [(1R) - (heterocyclyl-thiocarbonyl) ethyl] azetidin-2-one derivative in the preparation of carbapenem antibiotics
US4769451A (en) Synthesis of carbapenems using n-substituted azetidinones
JPS63188662A (en) Production of novel beta-lactam derivative
JPS6228786B2 (en)
PL163376B1 (en) Method of obtaining pheneme derivatives
US7902381B2 (en) Synthesising method and benzoxathiepine intermediates
US5225552A (en) 4-cyclohexenyl azetidinone derivatives
US4895940A (en) Process for the preparation of penems
KR100283608B1 (en) Method of preparing 1-betamethyl-2-formyl carbapenem derivatives
KR0129696B1 (en) New preparation of 2- (2-substituted pyrrolidin-4-yl) thio-carbapenem derivatives
US4973687A (en) Synthesis of carbapenems using N-substituted azetidinones
JPH0725848A (en) Production of 4-substituted azetidinone derivative
JP2003064087A (en) Crystals of azetidinone compounds

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees